Ming-Hui Chen's Selected Publications

1. Walburn, T., Chen, M.-H., Loffredo, M., McMahon, E., Orio, P.F., Nguyen, P.L., Anthony V. D'Amico, A.V., and Sayan, M. (2024). Secondary analysis of late major gastrointestinal and genitourinary toxicities in unfavorable-risk prostate cancer patients receiving docetaxel: Insights from a randomized trial. Cancer, https://doi.org/10.1002/cncr.35274
2. Chen, J., Zhao, T., Li, H., Xu, W., Maas, K., Singh, V., Chen, M.-H., Dorsey, S.G., Starkweather, A.R., and Cong, X.S. (2024). Multi-Omics Analysis of Gut Microbiota and Host Transcriptomics Reveal Dysregulated Immune Response and Metabolism in Young Adults with Irritable Bowel Syndrome. International Journal of Molecular Sciences, 25, 3514. https://doi.org/10.3390/ijms25063514
3. Ma, Z. and Chen, M.-H. (2024). A Bayesian model-based reduced major axis regression. Biometrical Journal, 66(3), 2300279. doi: 10.1002/bimj.202300279.
4. Zhao, T., Chang, X., Biswas, S.K., Balsbaugh, J.L., Liddle, J., Chen, M.-H., Matson, A.P., Alder, N.N., and Cong, X. (2024). Pain/Stress, Mitochondrial Dysfunction and Neurodevelopment in Preterm Infants. Developmental Neuroscience, https://doi.org/10.1159/000536509
5. Liu, P., Chen, M.-H., Sinks, S., and Sun, P. (2024). Are the Tests Overpowered or Underpowered? A Unified Solution to Correctly Specify Type I Errors in Design of Clinical Trials for Two Sample Proportions. Statistics in Medicine, 43, 1688-1707.
6. Menger, A., Sheikh, Md. T, and Chen, M.-H. (2023). Bayesian Modeling of Survival Data in the Presence of Competing Risks with Cure Fractions and Masked Causes. Sankhya A. To appear.
7. Huang, C., Chu, C., Lu, Y., Yi, B., and Chen, M.-H. (2023). Bayesian Interim Analysis in Basket Trials. The New England Journal of Statistics in Data Science. To appear. https://doi.org/10.51387/23-NEJSDS48
8. Wu, W., Yackel, H.D., Salner, A., Chen, M.-H., Judge, M.P., Cong, X., and Xu, W. (2024). Work-health balance of cancer survivors returning to work: A meta-ethnography. European Journal of Oncology Nursing, 68, 102482. https://doi.org/10.1016/j.ejon.2023.102482
9. Kearney, G., Chen, M.-H., Mula-Hussain, L., Skelton, M., Eren, M.F., Orio, P.F., Nguyen, P.L., D'Amico, A.V., and Sayan, M. (2023). Burden of prostate cancer in the Middle East: A comparative analysis based on global cancer observatory data. Cancer Medicine, 12(23), 21419-21425.
10. Sayan, M., Huang, J., Xie, W., Chen, M.-H., Loffredo, M., McMahon, E., Orio, P., Nguyen, P., and D'Amico, A.V. (2023). Risk of Short-Term Prostate-Specific Antigen Recurrence and Failure in Patients With Prostate Cancer: A Secondary Analysis of a Randomized Clinical Trial. JAMA Network Open, 6(10), e2336390-e2336390.
11. Sakaki, J.R., Rodriguez, N.R., Fernandez, M.L., Puglisi, M.J., Chen, M.-H., Chun, O.K. (2023). Fruit juice and childhood obesity: a review of epidemiologic studies. Critical Reviews in Food Science and Nutrition 63 (24), 6723-6737.
12. Chen, J., Wang, Z., Starkweather, A., Chen, M.-H., McCauley, P., Miao, H., Ahn, H., and Cong, X. (2023). Pain sensation and gut microbiota profiles in older adults with heart failure. Interdisciplinary Nursing Research, 2(2), 83–91.
13. Kiernan, P.A., Day, C.A., Berkowsky, R.S., Zaleski, A.L., Gao, S., Taylor, B.A., Santos, L.P., Panza, G., Kramarz, M., McCormick, K., Thompson, P.D., Fernandez, A.B., Chen, M.-H., and Pescatello, L.S. (2024). Reliability and Time Course of Postexercise Hypotension During Exercise Training Among Adults With Hypertension. Journal of Cardiovascular Development and Disease, 11(2), 42. https://doi.org/10.3390/jcdd11020042
14. Chen, J., Li, H. , Zhao, T., Chen, K., Chen, M.-H., Sun, Z., Xu, W., Maas, K., Lester, B.M., and Cong, X. (2023). The Impact of Early Life Experiences and Gut Microbiota on Neurobehavioral Development in Preterm Infants: A Longitudinal Cohort Study. Microorganisms 11 (3), 814.
15. Wu, J., de Castro, M, and Chen, M.-H. (2023). Bayesian Survival Analysis in the Presence of Monotone Likelihoods. In: Pham, H. (eds) Springer Handbook of Engineering Statistics. Springer Handbooks. Springer, London. pp. 921--930. https://doi.org/10.1007/978-1-4471-7503-2_45.
16. Wu, J., Geng, L., Starkweather, A., and Chen, M.-H. (2023). Modeling and maximum likelihood based inference of interval-censored data with unknown upper limits and time-dependent covariates. Statistics in Medicine, 42, 2455-2474.
17. Sabbagh, A., Washington, S.L., Tilki, D., Hong, J.C., Feng, J., Valdes, G., Chen, M.-H., Wu, J., Huland, H., Graefen, M., Wiegel, T., B$\ddot{\rm o}$hmer, D., Cowan, J.E., Cooperberg, M., Feng, F.Y., Roach, M., Trock, B.J., Partin, A.W., D'Amico, A.V., Carroll, P.R., and Mohamad, O. (2023). Development and external validation of a machine learning model for prediction of lymph node metastasis in patients with prostate cancer. European Urology Oncology, 6(5), 501-507. https://doi.org/10.1016/j.euo.2023.02.006
18. Brown, J., Chang, X., Matson, A., Lainwala, S., Chen, M.-H., Cong, X., and Casavant, S.G. (2023). Health disparities in preterm births. Frontiers in Public Health, 11. https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2023.1275776
19. Han, Z., Zhang, Q., Wang, M., Ye, K., and Chen, M.-H. (2023). On efficient posterior inference in normalized power prior Bayesian analysis. Biometrical Journal, 65, 2200194. https://doi.org/10.1002/bimj.202200194.
20. Wang, Y.-B., Milkey, A., Li, A., Chen, M.-H., Kuo, L., and Lewis, P.O. (2023). LoRaD: marginal likelihood estimation with haste (but no waste). Systematic Biology, 72(3), 639-648.
21. Tilki, D., Chen, M.-H., Wu, J., Huland, H., Graefen, M., Mohamad, O., Cowan, J.E., Feng, F.Y., Carroll, P.R., and D'Amico, A.V. (2023). PSA level at the time of Salvage Therapy following Radical Prostatectomy for Prostate Cancer and the Risk of Death. {\it Journal of Clinical Oncology, 41(13), 2428. https://doi.org/10. 1200/JCO.22.02489.
22. Sheikh, Md. T, Chen, M.-H., Gelfond, J.A., Sun, W., and Ibrahim, J.G. (2023). New Bayesian C-indices for Assessing Importance of Longitudinal Biomarkers in Fitting Competing Risks Survival Data in the Presence of Partially Masked Causes. Statistics in Medicine, 42, 1308-1322. https://doi.org/10.1002/sim.9671.
23. Hu, G., Chen, M.-H., and Ravishanker, N. (2023). Bayesian analysis of spherically parameterized dynamic multivariate stochastic volatility models. Computational Statistics, 38(2), 845-869. https://doi.org/10.1007/s00180-022-01266-9
24. Sakaki, J.R., Rodriguez, N.R., Fernandez, M-L., Puglisi, M.J., Chen, M.-H., and Chun, O.K. (2023). Fruit juice and childhood obesity: a review of epidemiologic studies. Critical Reviews in Food Science and Nutrition, 63(24), 6723-6737. https://doi.org/10.1080/10408398.2022.2044284.
25. Berkowsky, R.S., Zaleski, A.L., Taylor, B.A., Chen, M.-H., Gans, K.M., Wu, Y., Parducci, P.M., Zhang, Y., Fernandez, A.B., and Pescatello, L.S. (2022). Cardiometabolic biomarkers and habitual caffeine consumption associate with the adverse ambulatory blood pressure response to strenuous physical exertion among firefighters. Nutrients, 14, 4025. https://doi.org/10.3390/nu14194025.
26. Chen, M.-H., Lim, D., Ravishanker, N., Linder, M.H., Bolduc, M., McKeon, B., and Nolan, S. (2022). Collaborative analysis for energy usage monitoring and management on a large university campus. Stat, 11. e513. https://doi.org/10.1002/sta4.513.
27. Lim, D., Chen, M.-H., Ibrahim, J.G., Kim, S., Shah, A.K., and Lin, J. (2022). {metapack}: An R Package for Bayesian Meta-Analysis and Network Meta-Analysis with a Unified Formula Interface. The R Journal, 14(3), 142-161.
28. Gelfond, J.A., Hernandez, B., Goros, M., Ibrahim, J.G., Chen, M.-H., Sun, W., Leach, R.J., Kattan, M.W., Thompson, I.M., Ankerst, D.P., Liss, M. (2022). Prediction of future risk of any and higher-grade prostate cancer based on the PLCO and SELECT trials. BMC Urology, 22(1), 1-9.
29. Zhao, T., Alder, N.N., Starkweather, A.R., Chen, M.-H., Matson, A.P., Wanli Xu, Balsbaugh, J.L., and Cong, X. (2022). Associations of mitochondrial function, stress, and neurodevelopmental outcomes in early life: A systematic review. Developmental Neuroscience, 44(6), 438-454.
30. Chen, J., Li, H., Maas, K., Starkweather, A., Chen, M.-H., and Cong, X. (2022). Sex-specific gut microbiome profiles among preterm infants during the neonatal intensive care hospitalization. Interdisciplinary Nursing Research, 1(1), 6-13.
31. Zhang, Y., Chen, M.-H., and Guo, F. (2022). Bayesian Criterion-based Assessments of Recurrent Event Models with Applications to Commercial Truck Driver Behavior Studies. Statistics in Medicine. To appear.
32. Sakaki, J.R., Gao, S., Ha, K., Chavarro, J.E., Chen, M.-H., Sun, Q., Hart, J.E., and Chun, O.C. (2022). Childhood beverage intake and risk of hypertension and hyperlipidemia in young adults. International Journal of Food Sciences and Nutrition, 73(7), 954-964.
33. Yuan, W., Chen, M.-H., and Zhong, J. (2022). Bayesian design of superiority trials: methods and applications. Statistics in Biopharmaceutical Research, 14(4), 433-443.
34. Zhang, J., Zhang, Y.-Y., Tao, J., and Chen, M.-H. (2022). Bayesian Item Response Theory Models with Flexible Generalized Logit Links. Applied Psychological Measurement, 46(5), 382--405. DOI: 10.1177/01466216221089343.
35. Chen, J., Zhang, Y., Barandouzi, Z.A., Lee, J., Zhao, T., Xu, W., Chen, M.-H., Feng, B., Starkweather, A., and Cong, X. (2022). The effect of self-management online modules plus nurse-led support on pain and quality of life among young adults with irritable bowel syndrome: a randomized controlled trial. International Journal of Nursing Studies, 132 , 104278. https://doi.org/10.1016/j.ijnurstu.2022.104278.
36. Tilki, D., Chen, M.-H., Wu, J., Huland, H., Graefen, M., and D'Amico A.V. (2022). Adjuvant versus Early Salvage Radiation Therapy following Radical Prostatectomy for pN1 Prostate Cancer and the Risk of Death. Journal of Clinical Oncology, 40(20), 2186-2192.
37. Schmidt, D.R., Bhagwat, M., Glazer, D.I., Chen, M.-H., Moteabbed, M., McMahon, E., Loffredo, M.J., Tempany, C.M., and D'Amico, A.V. (2022). MRI-Based Radiotherapy Planning to Reduce Rectal Dose in Excess of Tolerance. Prostate Cancer, Volume 2022 , Article ID 7930744, https://doi.org/10.1155/2022/7930744.
38. Lim, D., Chen, M.-H., Ravishanker, N., Bolduc, M., McKeon, B., and Nolan, S. (2022). A Hybrid Monitoring Procedure for Detecting Abnormality with Application to Energy Consumption Data. Journal of Data Science, 20(2) , 135-155.
39. Liu, F., Wang, X., Hancock, R., and Chen, M.-H. (2022). Bayesian Model Assessment for Jointly Modeling Multidimensional Response Data With Application To Computerized Testing. Psychometrika, 87, 1290-1317. https://doi.org/10.1007/s11336-022-09845-x.
40. Liu, Y., Lu, B., Foster, R., Zhang, Y., Zhong, J., Chen, M.-H., and Sun, P. (2022). Matching Design for Augmenting the Control Arm of a Randomized Controlled Trial Using Real-World Data. Journal of Biopharmaceutical Statistics, 32(1) , 124-140.
41. Baron, E., Zhu, J., Tang, R., and Chen, M.-H. (2022). Bayesian Divide-and-Conquer Propensity Score Based Approaches for Leveraging Real World Data in Single Arm Clinical Trials. Journal of Biopharmaceutical Statistics, 32(1), 75-89.
42. Sheikh, Md. T., Chen, M.-H., Gelfond, J.A., and Ibrahim, J.G. (2022). A Power Prior Approach for Leveraging External Longitudinal and Competing Risks Survival Data within the Joint Modeling Framework. Statistics in Biosciences, 14, 318-336. https://doi.org/10.1007/s12561-021-09330-6.
43. Yuan, W., Chen, M.-H., and Zhong, J. (2022). Flexible Conditional Borrowing Approaches for Leveraging Historical Data in the Bayesian Design of Superiority Trials. Statistics in Biosciences, 14, 197-215. https://doi.org/10.1007/s12561-021-09321-7.
44. Shi, W., Chen, M.-H., Kuo, L., and Lewis, P.O. (2022). Bayesian Concentration Ratio and Dissonance. Bayesian Analysis, 17(3), 817-847.
45. Joeng, H.-K., Adeniji, A.K., Ting, N., and Chen, M.-H. (2022). Estimation of Discrete Survival Function through Modeling Diagnostic Accuracy for Mismeasured Outcome Data. Statistics in Biosciences, 14 , 105-138.
46. Ramanathan, P., Liu, R., Chen, M.-H., and Kennedy, M.R.T. (2022). Memory and executive functions subserving judgments of learning: cognitive reorganization after traumatic brain injury. Neuropsychological Rehabilitation, 32, 2203-2226. DOI: 10.1080/09602011.2021.1929345.
47. Chen, J., Li, H., Hird, S.M., Chen, M.-H., Xu, W., Maas, K., and Cong, X. (2021). Sex Differences in Gut Microbial Development of Preterm Infant Twins in Early Life: A Longitudinal Analysis. Frontiers in Cellular and Infection Microbiology, 11, Article 671074. doi: 10.3389/fcimb.2021.671074.
48. Casavant, S., Li, H., Reese, B., Chen, M.-H., and Cong, X. (2021). Pilot Study of Absolute Telomere Lengths in Preterm Infants. Nursing Research, 70(6), 481-486.
49. Casavant, S., Chen, J., Xu, W., Lainwala, S., Matson, A., Chen, M.-H., Starkweather, A., Maas, K., and Cong, X. (2021). Multi-Omics Analysis on Neurodevelopment in Preterm Neonates: A Protocol Paper. Nursing Research, 70(6), 462-468.
50. Liu, F., Zhang, J., Shi, N., and Chen, M.-H. (2021). A generalized semi-parametric model for jointly analyzing response times and accuracy in computerized testing. Statistics and Its Interface, 15(1), 91-104.
51. Wu, Y., Senk, C., Coll, P., Glenney, S., Zaborowski, K., Fortinsky, R., Taylor, B., Park, C., Benson, K., McGowan, M., Slyvia DiBiasi, S., Chen, M.-H., and Pescatello, L. (2021). A comparison of two Tai Chi interventions tailored for different health outcomes. Complementary Therapies in Medicine, 59, 102731. https://doi.org/10.1016/j.ctim.2021.102731.
52. Zhang, Y., Adeniji, A.K., and Chen, M.-H. (2021). A flexible non-parametric procedure for testing cumulative hazards with application to oncology studies. Journal of Statistical Research, 55(1), 75-100.
53. Tilki, D., Chen, M.-H., Wu, J., Huland, H., Graefen, M., Wiegel, T., B\"{o}hmer, D., Mohamad, O., Cowan, J.E., Feng, F.Y., Carroll, P.R., Trock, B.J., Partin, A.W., and D'Amico, A.V. (2021). Adjuvant versus Early Salvage Radiation Therapy for Men at High-Risk for Recurrence following Radical Prostatectomy for Prostate Cancer and the Risk of Death. Journal of Clinical Oncology . To appear.
54. King, M.T., Chen, M.-H., Collette, L., Neven, A., Bolla, M., and D'Amico, A.V. (2021). Association of prostate-specific antigen failure and mortality in men with locally advanced versus localized prostate cancer. JAMA Network Open, 4(5), e2111092. doi:10.1001/jamanetworkopen.2021.11092.
55. Shi, D., Chen, M.-H., Kuo, L., and Lewis, P.O. (2021). New partition based measures for data compatibility and information gain. Statistics in Medicine, 40, 3560-3581.
56. Li, H., Lim, D., Chen, M.-H., Ibrahim, J.G., Kim, S., Shah, A.K., and Lin, J. (2021). Bayesian Network Meta-Regression Hierarchical Models Using Heavy-Tailed Multivariate Random Effects with Covariate-Dependent Variances. Statistics in Medicine, 40, 3582-3603.
57. Chen, J., Zhang, Y., Simonsick, E., Starkweather, A., Chen, M.-H., McCauley, P., Chyun, D., Cong, X. (2021). Back pain and heart failure in community-dwelling older adults: Findings from the health ABC study. Geriatric Nursing, 42(3), 643-649.
58. Bitterman, D.S., Chen, M.-H., Wu, J., Renshaw, A.A., Loffredo, M., Kantoff, P.W., Small, E.J., D'Amico, A.D. (2021). PSA nadir and testosterone level at PSA failure following radiation and androgen suppression therapy for unfavorable risk prostate cancer and the risk of all cause and prostate cancer-specific mortality. Cancer. To appear.
59. Kim, D.W., Chen, M.-H., Wu, J., Huland, H., Graefen, M., Tilki, D., D'Amico, A.V. (2021). PSA ≤4 versus >4 ng/mL and the Risk of Prostate Cancer-Specific Mortality in Men with Biopsy Gleason Score 9-10 Prostate Cancer. Cancer. To appear.
60. Cilhoroz, B., Zaleski, A., Taylor, B.A., Fernhall, B., Chen, M.-H., Thompson, P.D., and Pescatello, L.S. (2021). The ambulatory blood pressure and heart rate variability responses following sudden vigorous physical exertion among firefighters with hypertension. Turkish Journal of Sports Medicine, 2021 Mar 02; http://dx.doi.org/10.47447/tjsm.0492.
61. Pescatello, L.S., Wu, Y., Gao, S., Livingstondc, J., Sheppard, B., and Chen, M.-H. (2021). Do the combined blood pressure effects of exercise and antihypertensive medications add up to the sum of their parts? A systematic meta-review. BMJ Open Sport & Exercise Medicine, 7, e000895. doi:10.1136/bmjsem-2020-000895.
62. Ma, Z., Hu, G., and Chen, M.-H. (2021). Bayesian Hierarchical Spatial Regression Models for Spatial Data in the Presence of Missing Covariates with Applications. Applied Stochastic Models in Business and Industry, 37, 342-359.
63. Sheikh, Md. T., Ibrahim, J.G., Gelfond, J.A., Sun, W., and Chen, M.-H. (2021). Joint Modelling of Longitudinal and Survival Data in the Presence of Competing Risks with Applications to Prostate Cancer Data. Statistical Modelling, 21(1-2), 72-94.
64. Zhang, F., Chen, M.-H., Cong, X., and Chen, Q. (2021). Assessing Importance of Biomarkers: a Bayesian Joint Modeling Approach of Longitudinal and Survival Data with Semicompeting Risks. Statistical Modelling, 21(1-2), 30-55.
65. Kim, S., Chen, M.-H., Ibrahim, J.G., Shah, A.K., and Lin, J. (2020). Bayesian Flexible Hierarchical Skew Heavy-Tailed Multivariate Meta Regression Models for Individual Patient Data with Applications. Statistics and Its Interface, 13, 485--500. DOI: 10.4310/20-SII613.
66. Gwon, Y., Mo, M., Chen, M.-H., Chi, Z., Li, J., Xia, H.A., and Ibrahim, J.G. (2020). Network Meta-Regression for Ordinal Outcomes: Applications in Comparing Crohn's Disease Treatments. Statistics in Medicine, 39, 1846--1870.
67. Kim, D.W., Chen, M.-H., Huland, H., Graefen, M., Tilki, D., and D'Amico, A.V. (2020). Advancing Age and the Risk of Adverse Pathology at Radical Prostatectomy in Men with Biopsy Gleason score 6 Prostate Cancer. JAMA Network Open, 3(4), e202041-e202041.
68. Chen, Q., Zhang, F., Chen, M.-H., and Cong, X. (2020). Estimation of Treatment Effects and Model Diagnostics with Two-way Time-Varying Treatment Switching: an Application to a Head and Neck Study. Lifetime Data Analysis, 26(4), 685--707.
69. de Castro, M., Chen, M.-H., Zhang, Y., and D'Amico, A.V. (2020). A Bayesian Multi-Risks Survival (MRS) Model in the Presence of Double Censorings. Biometrics, 76, 1297--1309.
70. Wu, J., de Castro, M., and Chen, M.-H. (2020). Bayesian Survival Analysis in the Presence of Monotone Likelihoods. in Springer Handbook of Engineering Statistics, 2nd (ed. H. Pham). To appear.
71. Liu, Y., Geng, L., Wang, X., Zhang, D., and Chen, M.-H. (2020). Subgroup Analysis from Bayesian Perspectives. In Design and Analysis of Subgroups with Biopharmaceutical Applications (eds. N. Ting, J.C. Cappelleri, S. Ho, and D.-D. Chen). New York: Springer. pp. 331--345.
72. Ma, Z., Chen, M.-H., and Tang, Y. (2020). Bayesian Meta-Regression Model Using Heavy-Tailed Random-effects with Missing Sample Sizes for Self-thinning Meta-data. Statistics and Its Interface, 13, 437-447.
73. Sun, W., Jin, C., Gelfond, J.A., Chen, M.-H., and Ibrahim, J.G. (2020). Joint Analysis of Single Cell and Bulk Tissue Sequencing Data to Infer Intra-Tumor Heterogeneity. Biometrics, 76, 983--994.
74. Wang, Y.-B., Wang, Y.-B., Chen, M.-H., Shi, W., Lewis, P.O., and Kuo, L. (2020). Inflated Density Ratio and Its Variation and Generalization for Computing Marginal Likelihoods. Journal of the Korean Statistical Society, 49, 244-263. https://doi.org/10.1007/s42952-019-00013-z.
75. Deng, Q., Zhang, Y.-Y., Roy, D., and Chen, M.-H. (2020). Superiority of Combining Two Independent Trials in Interim Futility Analysis. Statistical Methods in Medical Research, 29(2), 522-540. doi: 10.1177/0962280219840383.
76. Sakaki, J., Melough, M.M., Li, J., Tamimi, R.M., Chavarro, J.E., Chen, M.-H., and Chun, O.K. (2019). Associations between 100% orange juice consumption and dietary, lifestyle and anthropometric characteristics in a cross-sectional study of U.S. children and adolescents. Nutrients, 11, 2687. doi:10.3390/nu11112687.
77. Wu, J., Chen, M.-H., Schifano, E.D., Ibrahim, J.G., and Fisher, J.D. (2019). A New Bayesian Joint Model for Longitudinal Count Data with Many Zeros, Intermittent Missingness, and Dropout with Applications to HIV Prevention Trials. Statistics in Medicine, 38, 5565-5586.
78. Leeman, J., Chen, M.-H., Huland, H., Graefen, M., D'Amico, A.V., and Derya Tilki, D. (2019). Advancing Age and the Odds of Upgrading and Upstaging at Radical Prostatectomy in Men with Gleason Score 6 Prostate Cancer. Clinical Genitourinary Cancer, 17(6), e1116-e1121. doi: 10.1016/j.clgc.2019.07.018.
79. Liu, Y., Hu, G., Cao, L., Wang, X., and Chen, M.-H. (2019). A Comparison of Monte Carlo Methods for Computing Marginal Likelihoods of Item Response Theory Models (with Discussion). Journal of the Korean Statistical Society, 48, 503-512 (https://doi.org/10.1016/j.jkss.2019.04.001) for the main paper and 522-523 (https://doi.org/10.1016/j.jkss.2019.07.001) for the rejoinder.
80. Yang, H.-C., Guanyu Hu, G., and Chen, M.-H. (2019). Bayesian Variable Selection for Pareto Regression Models with Latent Multivariate Log Gamma Process with Applications to Earthquake Magnitudes. Geosciences Journal, 9(4), 169.
81. Zaleski, A.L., Taylor, B.A., Park, C.L., Santos, L.P., Panza, G.A., Kramarz, M., McCormick, K., Thompson, P.D., Fernandez, A.B., Chen, M.-H., Blissmer, B., Gans, K.M., and Pescatello L.S. (2019). Using the Immediate Blood Pressure Benefits of Exercise to Improve Exercise Adherence Among Adults with Hypertension: A Randomized Clinical Trial. Journal of Hypertension 37 (9), 1877-1888. doi: 10.1097/HJH.0000000000002115.
82. Liu, Y., Ma, X., Zhang, D., Geng, L., Wang, X., Zheng, W., and Chen, M.-H. (2019). Look Before You Leap: Systematic Evaluation of Tree-based Statistical Methods in Subgroup Identification. Journal of Biopharmaceutical Statistics, 29(6), 1082-1102.
83. Neupane, S., Fuvcikova, K., Lewis, L., Kuo, L., Chen, M.-H., and Lewis, P.O. (2019). Assessing Combinability of Phylogenomic Data using Bayes Factors. Systematic Biology, 68(5), 744-754. https://doi.org/10.1093/sysbio/syz007.
84. Pike, L.R.G., Wu, J., Chen, M.-H., Loffredo, M., Renshaw, A.A., Pfail, J., Kantoff, P.W., and D'Amico, A.V. (2019). Time to PSA Nadir and the Risk of Death from Prostate Cancer following Radiation and Androgen Deprivation Therapy. Urology, 126, 145-151. https://doi.org/10.1016/j.urology.2018.11.056.
85. Lachos, V.H., Matos, L.A., Castro, L.M., and Chen, M.-H. (2019). Flexible Longitudinal Linear Mixed Models for Multiple Censored Responses Data. Statistics in Medicine, 38(6), 1074-1102. doi: 10.1002/sim.8017.
86. Cilhoroz, B.T., Schifano, E.D., Ash, G.I., Panza, G.A., Corso, L., Chen, M.-H., Deshpande, V., Zaleski, A., Farinatti, P., Santos, L.P., Taylor, B.A., O'Neill, R.J., Thompson, P.D., and Pescatello, L.S. (2019). Furin variant associations with postexercise hypotension are intensity and race dependent. Physiological Reports, 7(3), e13952. https://doi.org/10.14814/phy2.13952.
87. Wang, Y.-B., Chen, M.-H., Kuo, L., and Lewis, P.O. (2019). Adaptive Partition Weighted Approach for Estimating Marginal Posterior Density with Applications. Journal of Computational and Graphical Statistics, 28(2), 334-349.
88. Ibrahim, J.G., Kim, S., Chen, M.-H., Shah, A.K., and Lin, J. (2019). Bayesian Multivariate Skew Meta-Regression Models for Individual Patient Data. Statistical Methods in Medical Research, 28(10-11), 3415-3436. DOI: 10.1177/0962280218801147.
89. Tilki, D., Chen, M.-H., Wu, J., Huland, H., Graefen, M., Braccioforte, M., Moran, B., and D'Amico, A.V. (2019). Surgery versus Radiation in the Management of Gleason Score 9,10 Prostate Cancer and the Risk of Death. JAMA Oncology, 5(2). 213-220. doi: 10.1001/jamaoncol.2018.4836.
90. Li, H., Chen, M.-H., Ibrahim, J.G., Kim, S., Shah, A.K., Lin, J., and Tershakovec, A.M. (2019). Bayesian inference for network meta-regression using multivariate random effects with applications to cholesterol lowering drugs. Biostatistics, 20(3), 499-516. doi:10.1093/biostatistics/kxy014.
91. Thomas, H.R., Chen, M.-H., D'Amico, A.V., Bennett, C.L., Kattan, M.W., Sartor, Q., Stein, K., and Nguyen, P.L. (2018). Association between Androgen Deprivation Therapy and Patient-Reported Depression in Men with Recurrent Prostate Cancer. Clinical Genitourinary Cancer, 16(4), 313-317.
92. Mahal, B.A., Chen, M.-H., Renshaw, A.A., Loffredo, M.J., Kantoff, P.W., and D'Amico A.V. (2018). Early versus Delayed Initiation of Salvage Androgen Deprivation Therapy and the Risk of Prostate Cancer-Specific Mortality. Journal of the National Comprehensive Cancer Network, 16(6), 727-734.
93. Hall, L.M., Hill, D.W., Bugduk, K., Cawley, S., Hall, L.H., Chen, M.-H., and Grant, D.F. (2018). Development of a Reverse Phase HPLC Retention Index Model for Nontargeted Metabolomics Using Synthetic Compounds. Journal of Chemical Information and Modeling, 58(3), 591-604. doi: 10.1021/acs.jcim.7b00496.
94. Wang, C., Chen, M.-H., Wu, J., Yan, J., Zhang, Y., and Schifano, E.D. (2018). Online updating method with new variables for big data streams. The Canadian Journal of Statistics, 46(1), 123-146. doi:10.1002/cjs.11330.
95. McDuff, S.G.R., Chen, M.-H., Renshaw, A.A., Loffredo, M., Kantoff, P.W., and D'Amico, A.V. (2018). Impact of Time to Testosterone Rebound and Comorbidity on the Risk of Cause-Specific Mortality in Men with Unfavorable-Risk Prostate Cancer. Cancer, 124(7), 1391-1399.
96. King, M., Chen, M.-H., Moran, B.J., Braccioforte, M.H., Buzurovic, I., Muralidhar, V., Yang, D.D., Mouw, K., Devlin, P.M., D'Amico, A.V., Nguyen, P.L., and Orio III, P.F. (2018). Brachytherapy Monotherapy May Be Sufficient for a Subset of Patients with Unfavorable Intermediate Risk Prostate Cancer. {\it Urologic Oncology: Seminars and Original Investigations, 36(4)}, 157.e15-157.e20. \url{doi: 10.1016/j.urolonc.2017.11.022}.
97. Atkins, K.M., Chen, M.-H., Wu, J., Renshaw, A.A., Loffredo, M., Kantoff, P.W., Small, E.J., and D'Amico, A.V. (2018). Low Testosterone at First PSA Failure and Assessment of the Risk of Death in Men with Unfavorable-Risk Prostate Cancer Treated on Prospective Clinical Trials. Cancer, 124(7), 1383-1390. doi: 10.1002/cncr.31204.
98. Kim, K., Vance, T.M., Chen, M.-H., and Chun, O.K. (2018). Dietary total antioxidant capacity is inversely associated with all-cause and cardiovascular disease death of U.S. adults. European Journal of Nutrition, 57(7), 2469-2476. doi: 10.1007/s00394-017-1519-7. Oct;57(7):2469-2476
99. Chen, K., Mishra, N., Smyth, J., Bar, H., Schifano, E.D., Kuo, L., and Chen, M.-H. (2018). A tailored multivariate mixture model for detecting proteins of concordant change in the pathogenesis of Necrotic Enteritis. Journal of the American Statistical Association, 113(522), 546-559. https://doi.org/10.1080/01621459.2017.1356314
100. Li, W., Chen, M.-H., Wang, X., and Dey, D.K. (2018). Bayesian Design of Non-Inferiority Clinical Trials via the Bayes Factor. Statistics in Biosciences, 10, 439-459. DOI: 10.1007/s12561-017-9200-5.
101. Wu, J., Ibrahim, J.G., Chen, M.-H., Schifano, E.D., and Fisher, J.D. (2018). Bayesian Modeling and Inference for Nonignorably Missing Longitudinal Binary Response Data with Applications to HIV Prevention Trials. Statistica Sinica, 28, 1929-1963. doi:10.5705/ss.202016.0319.
102. Wang, Y.-B., Chen, M.-H., Kuo, L., and Lewis, P.O. (2018). A New Monte Carlo Method for Estimating Marginal Likelihoods. Bayesian Analysis, 13(2), 311-333.
103. Mihalcik, S.A., Chen, M.-H., Braccioforte, M.H., Moran, B.J., and D'Amico, A.V. (2018). Comorbidity and the receipt of curative therapy for favorable risk prostate cancer prior to and following the publication of the PIVOT. European Urology Focus, 4(1), 64-67. https://doi.org/10.1016/j.euf.2016.02.007
104. Pescatello, L.S., Schifano, E.D., Ash, G.I., Panza, G.A., Lamberti, L., Chen, M.-H., Deshpande, V., Zaleski, A., Cilhoroz, B., Farinatt, P., Taylor, B.A., O'Neil, R., and Thompson, P.D. (2017). Deep-Targeted Sequencing of Endothelial Nitric Oxide Synthase Gene Exons Uncover Exercise Intensity and Ethnicity Dependent Associations with Postexercise Hypotension. Physiological Reports, 5 (22), e13510. https://doi.org/10.14814/phy2.13510.
105. Pescatello, L.S., Corso, L.M.L., MacDonald, H.V., Thompson, P.D., Taylor, B.A., Panza, G.A., Zaleski, A.L., Johnson, B.T., and Chen, M.-H. (2017). Small Sample Sizes Confound Understanding of Cardiometabolic Responses to Exercise. Exercise and Sport Sciences Reviews, 45(3), 173-180. doi: 10.1249/JES.0000000000000115.
106. Wu, J., de Castro, M., Schifano, E.D., and Chen, M.-H. (2017). Assessing covariate effects using Jeffreys-type prior in the Cox model in the presence of a monotone partial likelihood. Journal of Statistical Theory and Practice, 12(1), 23-41. http://dx.doi.org/10.1080/15598608.2017.1299058.
107. Abanto-Valle, C.A., Langrock, R., Chen, M.-H., and Cardoso, M.V. (2017). Maximum likelihood estimation for stochastic volatility in mean models with heavy-tailed distributions. Applied Stochastic Models in Business and Industry, 33, 394-408.
108. Leao, W.L., Abanto-Valle, C.A., and Chen, M.-H. (2017). Bayesian Analysis of Stochastic volatility-in-mean model with leverage and asymmetrically heavy-tailed error using Generalized Hyperbolic skew Student's t-distribution. Statistics and Its Interface, 10, 529-541.
109. Patel, S.A., Chen, M.-H., Loffredo, M., Renshaw, A.A., Kantoff, P.W., and D'Amico, A.V. (2017). The impact of comorbidity and PSA doubling time on the risk of death in men experiencing PSA failure following radiation therapy with or with androgen deprivation therapy for unfavorable-risk prostate cancer. Prostate Cancer and Prostatic Diseases, 20(2), 234-240. doi: 10.1038/pcan.2016.74.
110. Royce, T.J., Chen, M.-H., Wu, J., Loffredo, M., Renshaw, A.A., Kantoff, P.W., and D'Amico, A.V. (2017). A Comparison of Surrogate Endpoints for All Cause Mortality in Men with Localized Unfavorable-Risk Prostate Cancer. JAMA Oncology, 3(5), 652-658. doi: 10.1001/jamaoncol.2016.5983.
111. Ash, G.I., Beth A. Taylor, B.A., Thompson, P.D., Macdonald, H.V., Lamberti, L., Chen, M.-H., Farinatti, P., Kraemer, W.J., Panza, G.A., Zaleski, A.L., Deshpande, V., Ballard, K.D., Mujtaba, M., White, C.M., and Pescatello, L.S. (2017). The Antihypertensive Effects of Aerobic versus Isometric Handgirp Resistance Exercise. Journal of Hypertension, 35(2), 291-299. doi: 10.1097/HJH.0000000000001176.
112. Martin, N.E., Chen, M.-H., Zhang, D., Richie, J.P., and D'Amico, A.V. (2017). Unfavorable Intermediate-Risk Prostate Cancer and the Odds of Upgrading to Gleason 8 or Higher at Prostatectomy. Clinical Genitourinary Cancer, 15(2), 237-241. doi: 10.1016/j.clgc.2016.06.001.
113. Zhang, D., Chen, M.-H., Ibrahim, J. G., Boye, M. E., and Shen, W. (2017). Bayesian model assessment in joint modeling of longitudinal and survival data with applications to cancer clinical trials. Journal of Computational and Graphical Statistics, 26(1), 121-133.
114. Sanford, N.N., Chen, M.-H., Loffredo, M., Renshaw, A., Kantoff, P.W., and D'Amico, A.V. (2017). Duration of the anti-androgen in men undergoing six months of an LHRH agonist and radiation therapy for unfavorable-risk prostate cancer and the risk of death. Prostate Cancer and Prostatic Diseases, 20(1), 79-84.
115. Pescatello, L.S., Elizabeth D. Schifano, E.D., Ash, G.I., Panza, G.A., Lamberti, L., Chen, M.-H., Deshpande, V., Zaleski, A., Farinatt, P., Taylor, B.A., and Thompson, P.D. (2016). Deep-targeted exon sequencing reveals renal polymorphisms associate with postexercise hypotension among African Americans. Physiological Reports, 4(19), e12992. doi: 10.14814/phy2.12992.
116. Wang, W., Chen, M.-H., Chiou, S.H., Lai, H.-C., Wang, X., Yan, J., Zhang, Z. (2016). Onset of Persistent Pseudomonas Aeruginosa Infection in Children with Cystic Fibrosis with Interval Censored Data BMC Medical Research Methodology, 16, 122. DOI: 10.1186/s12874-016-0220-5.
117. Rose, B.S., Chen, M.-H., Wu, J., Braccioforte, M.H., Moran, B.J., Doseretz, D.E., Katin, M.J., Ross, R.H., Salenius, S.A., and D’Amico, A.V. (2016). Androgen Deprivation Therapy Use in the Setting of High-Dose Radiation Therapy and the Risk of Prostate Cancer-Specific Mortality Stratified by the Extent of Competing Mortality. International Journal of Radiation Oncology, Biology, Physics, 96(4), 778-784.
118. Giacalone, N.J., Wu, J., Chen, M.-H., Renshaw, A., Loffredo, M., Kantoff, P.W., and D'Amico, A.V. (2016). PSA Failure and the Risk of Death within Co-Morbidity Subgroups Among Men with Unfavorable-Risk Prostate Cancer Treated on a Randomized Trial. Journal of Clinical Oncology, 34(31), 3781-3786
119. Kovtun, K.A., Chen, M.-H., Braccioforte, M.H., Moran, B.J., and D'Amico, A.V. (2016). Race and mortality risk following radiation therapy in men treated with or without androgen suppression therapy for favorable-risk prostate cancer. Cancer, 122(23), 3608-3614.
120. Warren, L.E.G., Chen, M.-H., Denham, J.W., Steigler, A.B., Renshaw, A.A., Loffredo, M., Kantoff, P.W., and Amico, A.V. (2016). Gleason score and the risk of cause-specific and all-cause mortality following radiation with or without 6 months of androgen deprivation therapy for men with unfavorable-risk prostate cancer. Journal of Radiation Oncology, 5(3), 301-308.
121. de Castro, M., Chen, M.-H., and Zhang, Y. (2016). Bayesian Frailty Models for Multi-state Survival Data. In Statistical Applications from Clinical Trials and Personalized Medicine to Finance and Business Analytics --- Selected Papers from the 2015 ICSA/Graybill Applied Statistics Symposium, Colorado State University, Fort Collins. Eds. Lin, J., Wang, B., Hu, X., Chen, K., and Liu, R., New York: Springer. pp. 37-48.
122. Dyer, M.A., Chen, M.-H., Braccioforte, M.H., Moran, B.J., and D'Amico, A.V. (2016). Comorbidity and Androgen Deprivation Therapy Use in Men Undergoing High-Dose Radiation for Unfavorable-Risk Prostate Cancer. Journal of Radiation Oncology, 5, 293-300.
123. Huynh, M.A., Chen, M.-H., Wu, J., Braccioforte, M.H., Moran, B.J., and Anthony V. D'Amico, A.V. (2016). Influence of Comorbidity on the Risk of Mortality in Men with Unfavorable-Risk Prostate Cancer Undergoing High-Dose Radiation Therapy Alone. International Journal of Radiation Oncology, Biology, Physics, 95(4), 1158-1167. http://dx.doi.org/10.1016/j.ijrobp.2016.03.004.
124. Lewis, P.O., Chen, M.-H., Kuo, L., Lewis, L.A., Fuvcikova, K., Neupane, S., Wang, Y.-B., and Shi, D. (2016). Estimating Bayesian Phylogenetic Information Content. Systematic Biology, 65(6), 1009-1023. doi:10.1093/sysbio/syw042.
125. Wang, C., Chen, M.-H., Schifano, E.D., Wu, J., and Yan, J. (2016). Statistical Methods and Computing for Big Data. Statistics and Its Interface, 9, 399-414.
126. Schifano, E.D., Wu, J., Wang, C., Yan, J., and Chen, M.-H. (2016). Online Updating of Statistical Inference in the Big Data Setting. Technometrics, 58(3), 393-403. DOI: 10.1080/00401706.2016.1142900.
127. Wang, X., Chen, M.-H., Kuo, R.C., and Dey D.K. (2016). Dynamic Spatial Pattern Recognition in Count Data. In New Developments in Statistical Modeling, Inference and Application --- Selected Papers from 2014 ICSA/KISS Joint Applied Statistics Symposium in Portland, OR. Eds. Z. Jin, M. Liu, and X. Luo. New York: Springer. pp. 185-202.
128. Huynh, M.A., Chen, M.-H., Wu, J., Braccioforte, M.H., Moran, B.J., and D'Amico, A.V. (2016). Gleason Score 3 + 5 or 5 + 3 versus 4 + 4 Prostate Cancer the Risk of Death. European Urology, 69, 976-979. doi: 10.1016/j.eururo.2015.08.054.
129. Zhang, D., Chen, M.-H., Ibrahim, J. G., Boye, M. E., and Shen, W. (2016). JMFit: A SAS Macro for Joint Models of Longitudinal and Survival Data. Journal of Statistical Software, 71(3). doi: 10.18637/jss.v071.i03.
130. Gonzalez-Fajardoa, L., Mahajanb, L.H., Ndayac, D., Hargrovea, D., Manautoua, J.E., Liangd, B.T., Chen, M.-H., Kasib, R.M., and Lu, X. (2016). Reduced In Vivo Toxicity of Doxorubicin by Encapsulation in Cholesterol-Containing Self-Assembled Nanoparticles. Pharmacological Research, 107, 93-101. doi:10.1016/j.phrs.2016.03.006.
131. Vance, T.M., Wang, Y., Su, J., Fontham, E.T.H., Steck, S.E., Arab, L., Bensen, J.T., Mohler, J.L., Chen, M.-H., and Chun, O.K. (2016). Dietary Total Antioxidant Capacity is Inversely Associated with Prostate Cancer Aggressiveness in a Population-Based Study. Nutrition and Cancer: An International Journal, 68(2), 214-224.
132. Vance, T.M., Azabdaftari, G., Pop, E.A., Lee, S.G., Su, L.J., Fontham, E.T.H., Bensen, J.T., Steck, S.E., Arab, L., Mohler, J.L., Chen, M.-H., Koo, S.I., and Chun, O.K. (2016). Intake of Dietary Antioxidants is Inversely Associated with Biomarkers of Oxidative Stress among Men with Prostate Cancer. British Journal of Nutrition, 115, 68-74.
133. Joeng, H.-K., Chen, M.-H., and Kang, S. (2016). Proportional Exponentiated Link Transformed Hazards (ELTH) Models for Discrete Time Survival Data with Application. Lifetime Data Analysis, 22, 38-62. DOI: 10.1007/s10985-015-9326-z.
134. Ibrahim, J.G., Gwon, Y., and Chen, M.-H. (2015). SAS Macro BSMED: Bayesian Survival Meta-Experimental Design Using Historical Data. In \emph{Modern Approaches to Clinical Trials Using SAS: Classical, Adaptive, and Bayesian Methods}. Eds. S.M. Menon and R.C. Zink. Gary, NC: SAS Institute Inc., pp 107-131.
135. Gelfond, J.A., Ibrahim, J.G., Chen, M.-H., Sun, W., K. Lewis, Kinahan, S., Hibbs, M., and Buffenstein, R. (2015). Homology cluster differential expression analysis for interspecies mRNA-Seq experiments. Statistical Applications in Genetics and Molecular Biology (SAGMB), 14(6), 507-516. DOI 10.1515/sagmb-2014-0056.
136. Lee, H., Ash, G.I., Angelopoulos, T.J., Gordon, P.M., Moyna, N.M., Visich, P.S., Zoeller, R.F., Gordish-Dressmanh, H., Deshpande, V., Chen, M.-H., Thompson, P.D., Hoffman, E.P., Devaney, J.M., and Pescatello, L.S. (2015). Obesity-Related Genetic Variants and their Associations with Physical Activity. Sports Medicine -- Open (2015) 1:34. DOI 10.1186/s40798-015-0036-6.
137. Chen, M.-H. and Ye, K. (2015). Bayesian Methods. In Advanced Medical Statistics, 2nd Edition. Eds. Y. Lu, J.Q. Fang, L. Tian, and H. Jin. Singapore: World Scientific. pp. 1229--1299.
138. Ibrahim, J.G., Chen, M.-H., Gwon, Y., and Chen, F. (2015). The Power Prior: Theory and Applications. Statistics in Medicine, 34, 3724-3749.
139. Zhu, H., Ibrahim, J.G., and Chen, M.-H. (2015). Diagnostic Measures for the Cox Regression Model with Missing Covariates. Biometrika, 102(4), 907-923.
140. Vance, T.M., Azabdaftari, G., Pop, E.A., Lee, S.G., Su, L.J., Fontham, E., Bensen, J.T., Steck, S.E., Arab, L., Mohler, J.L., Chen, M.-H., Koo, S.I., and Chun, O.K. (2015). ``Thioredoxin 1 in Prostate Tissue is Associated with Gleason Score, Erythrocyte Antioxidant Enzyme Activity, and Dietary Antioxidants". Prostate Cancer. Volume 2015, Article ID 728046.
141. Muralidhar, V., Chen, M.-H., Reznor, G., Moran, B.J., Braccioforte, M.H., Beard, C.J., Feng, F.Y., Hoffman, K.E., Choueiri, T.K., Martin, N., Sweeney, C.J., Trinh, Q.-D., and Nguyen, P.L. (2015). Definition and validation of ``favorable high-risk prostate cancer": implications for personalizing treatment of radiation-managed patients. International Journal of Radiation Oncology, Biology, Physics, 93(4), 828-835. doi: 10.1016/j.ijrobp.2015.07.2281.
142. Yu, F., Chen, M.-H., Kuo, L., Talbott, H., and Davis, J.S. (2015). Confident Difference Criterion: A New Bayesian Differentially Expressed Gene Selection Algorithm with Applications. BMC Bioinformatics, 16, 245. DOI 10.1186/s12859-015-0664-3.
143. D'Amico, A.V., Chen, M.-H., Renshaw, A., Loffredo, M., and Kantoff, P.W. (2015). Long-Term Follow-up of a Randomized Trial of Radiation with or without Androgen Deprivation Therapy for Localized Prostate Cancer. The Journal of the American Medical Association, 314(12), 1291-1293.
144. Braunstein, L.Z., Chen, M.-H., Dosoretz, D.E., Salenius, S.A., Katin, M.J., Nanda, A., and D'Amico, A.V. (2015). Whole Pelvis Versus Prostate-Only Radiotherapy With or Without Short-Course Androgen Deprivation Therapy and Mortality Risk. Clinical Genitourinary Cancer, 13(6), 555-561. doi: 10.1016/j.clgc.2015.04.010.
145. Ennis, K.Y., Chen, M.-H., Smith, G.C., D'Amico, A.V., Zhang, Y., Quinn, S.A., Ryemon, S.N., Goltz, D., Harrison, L.B., and Ennis, R.D. (2015). The Impact of Economic Recession on the Incidence and Treatment of Cancer. Journal of Cancer, 6(8), 727-733. doi: 10.7150/jca.11886.
146. Mahal, B.A., Chen, M.-H., Bennett, C.L., Kattan, M.W., Sartor, O., Stein, K., D'Amico, A.V., and Nguyen, P.L. (2015). High PSA anxiety and Low health literacy skills: drivers of early use of salvage ADT among men with biochemically recurrent prostate cancer after radiotherapy? Annals of Oncology, 26(7), 1390-1395. doi: 10.1093/annonc/mdv185.
147. Keane, F.K., Chen, M.-H., Zhang, D., Moran, B.J., Braccioforte, M., and D'Amico, A.V. (2015). Androgen deprivation therapy and the risk of death from prostate cancer among men with favorable or unfavorable intermediate-risk disease. Cancer, 121(16), 2713-2719. doi: 10.1002/cncr.29420.
148. Chandra, R.A., Chen, M.-H., Zhang, D., Loffredo, M., and D'Amico, A.V. (2015). Age, Comorbidity, and the Risk of Prostate Cancer-Specific Mortality in Men with Biopsy Gleason Score 4+3: Implications on Patient Selection for Multiparametric MRI. Clinical Genitourinary Cancer, 13(4), 400-405. doi: 10.1016/j.clgc.2015.03.001.
149. Cheney, M.D., Zhang, D., Chen, M.-H., Richie, J.P., and D'Amico, A.V. (2015). Greatest Percent Involved Core Length and the Risk of Clinically Significant Prostate Specific Antigen Failure Following Radical Prostatectomy. Clinical Genitourinary Cancer, 13(4), 338-343. doi: 10.1016/j.clgc.2015.02.012.
150. de Castro, M., Chen, M.-H., and Zhang, Y. (2015). Bayesian Path Specific Frailty Models for Multi-state Survival Data with Applications. Biometrics, 71, 760-771.
151. Yao, H., Kim, S., Chen, M.-H., Ibrahim, J.G., Shah, A.K., and Lin, J. (2015). Bayesian Inference for Multivariate Meta-regression with Partially Observed Within-Study Sample Covariance Matrix. Journal of the American Statistical Association, 110(510), 528-544.
152. Raldow, A.C., Zhang, D., Chen, M.-H., Braccioforte, M.H., Moran, B.J., and D'Amico, A.V. (2015). Short-course androgen deprivation therapy and the risk of death from high-risk prostate cancer in men undergoing external beam radiation therapy and brachytherapy. Brachytherapy, 14(6),781-787. doi: 10.1016/j.brachy.2015.08.004.
153. Raldow, A.C., Zhang, D., Chen, M.-H., Braccioforte, M.H., Moran, B.J., and D'Amico, A.V. (2015). Risk Group and Death from Prostate Cancer: Implications for Active Surveillance in Men with Favorable Intermediate-Risk Prostate Cancer. JAMA Oncology, 1(3), 334-340.
154. Hall, L.M., Menikarachchi, L.C., Chen, M.-H., Hall, L.H., and David F Grant, D.F. (2015). Optimizing artificial neural network models for metabolomics and systems biology: an example using HPLC retention index data. Bioanalysis, 7(8), 939-955.
155. Aizer, A.A., Gu, X., Chen, M.-H., Choueiri, T.K., Martin, N.E., Efstathiou, J.A., Hyatt, A.S., Graham, P.L., Trinh, Q.-D., Hu, J.C., and Nguyen, P.L. (2015). Cost Implications and Complications of Overtreatment of Low-Risk Prostate Cancer in the United States. Journal of the National Comprehensive Cancer Network, 13(1), 61-68.
156. Sinha, A., Chi, Z., and Chen, M.-H. (2015). Bayesian Inference of Hidden Gamma Wear Process Model for Survival Data with Ties. Statistica Sinica, 25, 1613-1635.
157. Parekh, A., Chen, M.-H., Graham, P., Mahal, B.A., Hirsch, A.E., Nakabayashi, M., Evan, C., Kantoff, P.W., Martin, N.E., and Nguyen, P.L. (2015). Role of Androgen Deprivation Therapy in Early Salvage Radiation Among Patients With Prostate-Specific Antigen Level of 0.5 or Less. Clinical Genitourinary Cancer, 13(1), e1-e6. http://dx.doi.org/10.1016/j.clgc.2014.06.016
158. Ibrahim, J.G., Chen, M.-H., Lakshminarayanan, M., Liu, G.F., and Heyse, J.F. (2015). Bayesian Probability of Success for Clinical Trials Using Historical Data. Statistics in Medicine, 34(2), 249-264.
159. Dubey, R., Hill, D.W., Lai, S., Chen, M.-H., and Grant, D.F. (2015). Correction of precursor and product ion relative abundances in order to standardize CID spectra and improve Ecom50 accuracy for non-targeted metabolomics. Metabolomics, 11(3), 753-763. DOI 10.1007/s11306-014-0732-0.
160. Mahal, B.A., Chen, M.-H., Bennett, C.L., Kattan, M.W., Sartor, O., Stein, K., D'Amico, A.V., and Nguyen, P.L. (2015). The Association between Race and Treatment Regret among Men with Recurrent Prostate Cancer. Prostate Cancer and Prostatic Diseases, 18(1), 38-42.
161. Zhang, D., Chen, M.-H., Ibrahim, J. G., Boye, M. E., and Shen, W. (2015). Assessment of fit in longitudinal data for joint models with applications to cancer clinical trials. In: Applied Statistics in Biomedicine and Clinical Trials Design - Selected Papers from 2013 ICSA/ISBS Joint Statistical Meetings. Eds. Z. Chen, A. Liu, Y. Qu, L. Tang, N. Ting, and Y. Tsong. New York: Springer. pp. 347-365.
162. Li, W., Chen, M.-H., Tan, H., and Dey, D.K. (2015). Bayesian Design of Non-Inferiority Clinical Trials with Co-Primary Endpoints and Multiple Dose Comparison. In: Applied Statistics in Biomedicine and Clinical Trials Design - Selected Papers from 2013 ICSA/ISBS Joint Statistical Meetings. Eds. Z. Chen, A. Liu, Y. Qu, L. Tang, N. Ting, and Y. Tsong. New York: Springer. pp. 17-33.
163. Ziehr, D.R., Chen, M.-H., Zhang, D., Braccioforte, M.H., Moran, B.J., Mahal, B.A., Hyatt, A.S., Basaria, S.S., Beard, C.J., Beckman, J.A., Choueiri, T.K., D'Amico, A.V., Hoffman, K.E., Hu, J.C., Martin, N.E., Sweeney, C.J., Trinh, Q.-D., and Nguyen, P.L. (2015). Association of Androgen Deprivation Therapy with Excess Cardiac-Specific Mortality in Men with Prostate Cancer. BJU International, 116(3), 358-365. doi: 10.1111/bju.12905.
164. Lachos, V.H., Chen, M.-H., Abanto-Valle, C.A., and Azevedo, C.L. (2015). Quantile Regression for Censored Mixed-Effects Models with Applications to HIV Studies. Statistics and Its Interface, 8(2), 203-215.
165. Chen, Q., Zeng, D., Ibrahim, J.G., Chen, M.-H., Pan, Z., and Xue, X. (2015). Quantifying the Average of Time-varying Hazard Ratio via a Class of Transformations. Lifetime Data Analysis, 21(2), 259-279.
166. M'lan, C.E. and Chen, M.-H. (2015). Objective Bayesian Inference for Bilateral Data. Bayesian Analysis, 10(1), 139-170.
167. Wang, X., Chen, M.-H., Kuo, R.C., and Dey, D.K. (2015). Bayesian Spatial-Temporal Modeling of Ecological Zero-Inflated Count Data. Statistica Sinica, 25, 189-204. http://dx.doi.org/10.5705/ss.2013.212w.
168. Zeng, D., Chen, M.-H., Ibrahim, J. G., Wei, R., Ding, B., Ke, C., and Jiang, Q. (2015). A Counterfactual P-value Approach for Benefit-Risk Assessment in Clinical Trials. Journal of Biopharmaceutical Statistics, 25(3), 508-524.
169. Hall, L.H., Hall, L.M., Hill, D.W., Hawkins, D.M., Chen, M.-H., and Grant, D.F. (2014). Development of a Two-Step Indirect Method for Modeling Ecom50. Current Computer-Aided Drug Design, 10(4), 374-382.
170. Ibrahim, J. G., Chen, M.-H., Xia, H. A., Liu, T., and Hennessey, V. (2014). Bayesian Meta-Experimental Design for Evaluating Cardiovascular Risk. In: Jiang Q. and Xia HA (eds) Quantitative Evaluation if Safety in Drug Development: Design, Analysis and Reporting. Boca Raton, FL: Chapman & Hall/CRC. pp. 13-38.
171. Pashtan, I., Chen, M.-H., and D'Amico, A.V. (2014). The impact of PSA and digital rectal examination on the risk of prostate cancer specific mortality in men with a PSA level < 2.5 ng/ml. Cancer Epidemiology, 38(5), 613-618.
172. Zhang, D., Chen, M.-H., Ibrahim, J. G., Boye, M. E., Wang, P., and Shen, W. (2014). Assessing Model Fit in Joint Models of Longitudinal and Survival Data with Applications to Cancer Clinical Trials. Statistics in Medicine, 33(27), 4715-4733.
173. Chen, M.-H., Ibrahim, J.G., Zeng, D., Hu, K., and Jia, C. (2014). Bayesian Design of Superiority Clinical Trials for Recurrent Events Data with Applications to Bleeding and Transfusion Events in Myelodyplastic Syndrome. Biometrics, 70, 1003-1013.
174. Aizer, A.A., Chen, M.-H., Parekh, A., Choueiri, T.K., Hoffman, K.E., Kim, S.P., Martin, N.E., Hu, J.C., Trinh, Q.D., and Nguyen, P.L. (2014). Refusal of Curative Radiation Therapy and Surgery Among Patients With Cancer. International Journal of Radiation Oncology, Biology, Physics, 89(4), 756-764. doi: 10.1016/j.ijrobp.2014.03.024.
175. Rose, B.S., Chen M.-H., Zhang, D., Hirsch, M.S., Richie, J.P., Chang, S.L., Hegde, J.V., Loffredo, M.J., D'Amico, A.V. (2014). Maximum Tumor Diameter and the Risk of Prostate-Specific Antigen Recurrence After Radical Prostatectomy. Clinical Genitourinary Cancer, 12(5), e173-179. doi:10.1016/j.clgc.2014.03.008.
176. Abanto-Valle, C.A., Wang, C., Wang, X., Wang, F.-X., and Chen, M.-H. (2014). Bayesian Stochastic Volatility Models Using the Generalized Skew-t Distribution with Applications to the Shenzhen Stock Exchange Returns. Statistics and Its Interface, 7, 487-502.
177. Braunstein, L.Z., Chen, M.-H., Loffredo, M., Kantoff, P.W., and D'Amico, A.V. (2014). Obesity and the Odds of Weight Gain Following Androgen Deprivation Therapy for Prostate Cancer. Prostate Cancer. Volume 2014, Article ID 230812. http://dx.doi.org/10.1155/2014/230812.
178. Tanguturi, S.K., Chen, M.-H., Loffredo, M., Richie, J.P., and D'Amico, A.V. (2014). Evaluating the Impact of Excluding PSA from the Selection Criteria for Nerve Sparing Radical Prostatectomy on the Risk of PSA Failure. Prostate Cancer, Volume 2014, Article ID 395078. http://dx.doi.org/10.1155/2014/395078.
179. Phillips, J.G., Aizer, A.A., Chen, M.-H., Zhang, D., Hirsch, M.S., Richie, J.P., Tempany, C.M., Williams, S., Hegde, J.V., Loedo, M., and D'Amico, A.V. (2014). The impact of diring Gleason scores at biopsy on the odds of upgrading and the risk of death from prostate cancer. Clinical Genitourinary Cancer, 12(5), e181-187. http://dx.doi.org/10.1016/j.clgc.2014.02.008.
180. Aizer, A.A., Falit, B., Mendu, M.L., Chen, M.-H., Choueiri, T.K., Hoffman, K.E., Hu, J.C., Martin, N.E, Trinh, Q.-D., Alexander, B., and Nguyen, P.L. (2014). Cancer-specific Outcomes among Young Adults without Health Insurance. Journal of Clinical Oncology, 32(19), 2025-2030. doi: 10.1200/JCO.2013.54.2555.
181. Cheney, M.D., Chen, M.-H., Zhang, D., Phillips, J.G., Loffredo, M.J., and D'Amico,, A.V. (2014). Greatest Percentage of Involved Core Length and the Risk of Death from Prostate Cancer in Men with Highest Gleason Score 7 or Higher. Clinical Genitourinary Cancer, 12(4), 234-240.
182. Wu, R., Chen, M.-H., Kuo, L., and Lewis, P.O. (2014). A New Method for Tracking Configuration for Dirichlet Process Sampling. Sri Lankan Journal of Applied Statistics, 5(4) (Special Issue), 1-16. http://dx.doi.org/10.4038/sljastats.v5i4.7781.
183. Mirabeau-Beale, K., Chen, M.-H., and D'Amico, A.V. (2014). Prior-Cancer Diagnosis in Men with Nonmetastatic Prostate Cancer and the Risk of Prostate-Cancer-Specific and All-Cause Mortality. ISRN Oncology, 2014:736163. http://dx.doi.org/10.1155/2014/736163.
184. Aizer, A.A., Wilhite, T.J., Chen, M.-H., Graham, P.L., Choueiri, T.K., Hoffman, K.E., Martin, N.E., Trinh, Q.-D., Hu, J.C., and Nguyen, P.L. (2014). Lack of reduction in racial disparities in cancer-specific mortality over a twenty-year period. Cancer, 120(10), 1532-1539.
185. Keane, F.K., Chen, M.-H., Zhang, D., Loffredo, M.J., Kantoff, P.W., Renshaw, A.A., and D'Amico, A.V. (2014). The Likelihood of Death from Prostate Cancer in Men with Favorable or Unfavorable Intermediate-Risk Disease. Cancer, 120(12), 1787-1793.
186. Martin, N.E., Chen, M.-H., Beard, C.J., Nguyen, P.L., Loffredo, M.J., Renshaw, A.A., Kantoff, P.W., and A. D'Amico, A.V. (2014). Natural history of untreated prostate specific antigen radiorecurrent prostate cancer in men with favorable prognostic indicators. Prostate Cancer. Volume 2014, Article ID 912943. http://dx.doi.org/10.1155/2014/912943.
187. Chandra, R.A., Chen, M.-H., Zhang, D., Loffredo, M.J., and D'Amico, A.V. (2014). Evidence Suggesting Obesity Prevention Measures May Improve Prostate Cancer Outcomes Using Data from a Prospective Randomized Trial. Prostate Cancer. Volume 2014, Article ID 478983. http://dx.doi.org/10.1155/2014/478983.
188. Chen, M.-H., Ibrahim, J. G., Xia, H. A., Liu, T., and Hennessey, V. (2014). Bayesian Sequential Meta-analysis Design in Evaluating Cardiovascular Risk in a New Antidiabetic Drug Development Program. Statistics in Medicine, 33, 1600-1618.
189. de Castro, M., Chen, M.-H., Ibrahim, J.G., and Klein, J.P. (2014). Bayesian Transformation Models for Multivariate Survival Data. Scandinavian Journal of Statistics, 41, 187-199.
190. Zeng, D., Ibrahim, J.G., Chen, M.-H., Hu, K., and Jia, C. (2014). Multivariate Recurrent Events in the Presence of Multivariate Informative Censoring with Applications to Bleeding and Transfusion Events in Myelodyplastic Syndrome. Journal of Biopharmaceutical Statistics, 24. 429-442.
191. Aizer, A.A., Chen, M.-H., Hattangadi, J., and D'Amico, A.V. (2014). Initial Management of PSA-detected, Low-risk Prostate Cancer and the Risk of Death from Prostate Cancer. British Journal of Urology International, 113(1), 43-50.
192. Nanda, A., Chen, M.-H., Morgan, B.J., Braccioforte, M.H., Dosoretz, D., Salenius, S., Katin, M., Ross, R., and D'Amico, A.V. (2014). Neoadjuvant Hormonal Therapy Use in Men with Prostate Cancer Treated with Brachytherapy who have No or at Least a Single Risk Factor for Coronary Artery Disease and the Risk of Death. European Urology, 65(1), 177-185.
193. Lewis, P.O., Xie, W., Chen, M.-H., Fan, Y., and Kuo, L. (2014). Posterior Predictive Bayesian Phylogenetic Model Selection. Systematic Biology, 63(3), 309-321.
194. Ibrahim, J.G., Chen, M.-H., Zhang, D., and Sinha, D. (2014). Bayesian Analysis of the Cox Model. In: Klein JK, van Houwelingen HC, Ibrahim JG, and Scheike TH (eds) Handbook of Survival Analysis. Boca Raton, FL: Chapman & Hall, pp. 27-48.
195. Chen, M.-H., de Castro, M., Ge, M., and Zhang, Y. (2014). Bayesian Regression Models for Competing Risks. In: Klein JK, van Houwelingen HC, Ibrahim JG, and Scheike TH (eds) Handbook of Survival Analysis. Boca Raton, FL: Chapman & Hall, pp. 179-198.
196. Zhang, Y., Chen, M.-H., Ibrahim, J.G., Zeng, D., Chen, Q., Pan, Z., and Xue, X. (2014). Bayesian Gamma Frailty Models for Survival Data with Semi-Competing Risks and Treatment Switching. Lifetime Data Analysis, 20, 76-105.
197. Gelfond, J.A., Ibrahim, J.G., Gupta, M., Chen, M.-H., and Cody, J.D. (2013). Differential Expression Analysis with Global Network Adjustment. BMC Bioinformatics, 14, 258. doi:10.1186/1471-2105-14-258.
198. Aizer, A.A., Chen, M.-H., McCarthy, E., Mendu, M.L., Koo, S., Wilhite, T.J., Graham, P.L., Choueiri, T.K., Hoffman, K.E., Martin, N.E., Hu, J.C., and Nguyen, P.L. (2013). Marital Status and Survival in Patients with Cancer. Journal of Clinical Oncology, 31(31), 3869-3876.
199. Kim, M.B., Chen, M.-H., de Castro, M., Loffredo, M., Kantoff, P.W., and D'Amico, A.V. (2013). Defining the Optimal Approach to the Patient with Post-Radiation Prostate-Specific Antigen Recurrence Using Outcome Data from a Prospective Randomized Trial. Cancer, 119(18), 3280-3286.
200. Parekh, A., Chen, M.-H., D'Amico, A.V., Dosoretz, D.E., Ross, R., Salenius, S., Graham, P.L., Beckman, J.A., Beard, C.J., Choueiri, T.K., Ennis, R.D., Hoffman, K.E., Hu, J.C., Ma, J., Martin, N.E., and Nguyen, P.L. (2013). Identification of Comorbidities that Place Men at Highest Risk of Death from Androgen Deprivation Therapy before Brachytherapy for Prostate Cancer. Brachytherapy 12(5), 415-421. doi: 10.1016/j.brachy.2013.02.005.
201. Chen, Q., Chen, M.-H., Ohlssen, D., and Ibrahim, J.G. (2013). Bayesian Modeling and Inference for Clinical Trials with Partial Retrieved Data Following Dropout. Statistics in Medicine, 32, 4180-4195.
202. Kim, S., Chen, M.-H., Ibrahim, J.G., Shah, A.K., and Lin, J. (2013). Bayesian Inference for Multivariate Meta-Analysis Box-Cox Transformation Models for Individual Patient Data with Applications to Evaluation of Cholesterol Lowering Drugs. Statistics in Medicine, 32, 3972-3990.
203. Zhang, Y., Chen, Q., Chen, M.-H., Ibrahim, J.G., Zeng, D., Pan, Z., and Xue, X. (2013). Bayesian Analysis of Survival Data with Semi-Competing Risks and Treatment Switching. In: Topics in Applied Statistics --- 2012 Symposium of the International Chinese Statistical Association. Eds. M. Hu, Y. Liu, and J. Lin. New York: Springer. pp. 159-169.
204. Fan, Y., Wu, R., Chen, M.-H., Kuo, L., and Lewis, P.O. (2013). A Conditional Autoregressive Model for Detecting Natural Selection in Protein-coding DNA Sequences. In: Topics in Applied Statistics --- 2012 Symposium of the International Chinese Statistical Association. Eds. M. Hu, Y. Liu, and J. Lin. New York: Springer. pp. 203-212.
205. Yu, F., Chen, M.-H., Huang, L., and Anderson, G.J. (2013). Hierarchical Bayesian Analysis of Repeated Binary data with Missing Covariates. In: Topics in Applied Statistics --- 2012 Symposium of the International Chinese Statistical Association, Eds. M. Hu, Y. Liu, and J. Lin. New York: Springer. pp. 311-322.
206. Beard, C.J., Travis, L.B., Chen, M.-H., Arvold, N.D., Nguyen, P.L., Martin, N.E., Kuban, D.A., Ng, A.K., and Hoffman, K.E. (2013). Outcomes in Stage I Testicular Seminoma: A Population-based Study of 9,193 Patients. Cancer, 119(15), 2771-2777.
207. Wang, X., Chen, M.-H., and Yan, J. (2013). Bayesian Dynamic Regression Models for Interval Censored Survival Data with Application to Children Dental Health. Lifetime Data Analysis, 19, 297-316.
208. Nanda, A., Chen, M.-H., Moran, B.J., Braccioforte, M.H., and D'Amico, A.V. (2013). Cardiovascular Comorbidity and Mortality in Men with Prostate Cancer Treated with Brachytherapy-based Radiation with or without Hormonal Therapy. International Journal of Radiation Oncology, Biology, Physics, 85(5), e209-215.
209. Matos, L.A., Prates, M.O., Chen, M.-H., and Lachos, V.L. (2013). Likelihood Based Inference for Mixed-Effects Models with Censored Response Using the Multivariate-t Distribution. Statistica Sinica, 23, 1323-1345.
210. Hegde, J.V., Chen, M.-H., Mulkern, R.V., Fennessy, F.M., D'Amico, A.V., and Tempany, C.M.C. (2013). Preoperative 3-Tesla multiparametric endorectal magnetic resonance imaging findings and the odds of upgrading and upstaging at radical prostatectomy in men with clinically localized prostate cancer. International Journal of Radiation Oncology, Biology, Physics, 85(2), e101-e107.
211. Parekh, A., Chen, M.-H., Hoffman, K.E., Choueiri, T.K., Hu, J.C., Bennett, C.L., Kattan, M.W., Sartor, O., Stein, K., Graham, P.L., D'Amico, A.V., and Nguyen, P.L. (2012). Reduced Penis Size and Treatment Regret in Men with Recurrent Prostate Cancer after Surgery, Radiation plus Androgen Deprivation, or Radiation Alone. Urology, 81(1), 130-134.
212. Ibrahim, J.G., Chen, M.-H., and Chu, H. (2012). Bayesian methods in clinical trials: a Bayesian analysis of ECOG trials E1684 and E1690. BMC Medical Research Methodology, 12, 183. doi: 10.1186/1471-2288-12-183.
213. Russo, A.L., Chen, M.-H., Aizer, A.A., Hattangadi, J.A., and D'Amico, A.V. (2012). Advancing Age within Established Gleason Score Categories and the Risk of Prostate Cancer-Specific Mortality. British Journal of Urology International, 110(7), 973-979.
214. Nguyen, P.L., Chen, M.-H., Zhang, Y., Tempany, C.M., Cormack, R.A., Beard, C.J., Hurwitz, M.D., Suh, W.W., and D'Amico, A.V. (2012). Updated Results of Magnetic Resonance Imaging Guided Partial Prostate Brachytherapy for Favorable Risk Prostate Cancer: Implications for Focal Therapy. Journal of Urology, 188(4), 1151-1156.
215. Hattangadi, J.A., Chen, M.-H., and D'Amico, A.V. (2012). Early Detection of High-Grade Prostate Cancer Using Digital Rectal Examination (DRE) in Men with a Prostate-Specific Antigen Level < 2.5 ng/ml and the Risk of Death. BJU International, 110(11), 1636-1641.
216. Hall, L.M., Hall, L.H., Kertesz, T.M., Hill, D.W., Sharp, T.R., Oblak, E.Z., Dong, Y.W., Wishart, D.S., Chen, M.-H., and Grant, D.F. (2012). Development of Ecom_50 and Retention Index models for Non-Targeted Metabolomics: Identification of 1,3-dicyclohexylurea in human serum by HPLC/Mass Spectrometry. Journal of Chemical Information and Modeling, 52(5), 1222-1237.
217. Ge, M. and Chen, M.-H. (2012). Bayesian Inference of the Fully Specified Subdistribution Model for Survival Data with Competing Risks. Lifetime Data Analysis, 18(3), 339-363. DOI: 10.1007/s10985-012-9221-9.
218. Wang, X., Sinha, A., Yan, J., and Chen, M.-H. (2012). Bayesian inference of interval-censored survival data. In: Chen DG, Sun J, Peace KE (eds) Interval-Censored Time-to-Event Data: Methods and Applications. Boca Raton, FL: Chapman & Hall, pp. 167-195.
219. Chen, M.-H., Ibrahim, J.G., Shah, A.K., Lin, J., and Yao, H. (2012). Meta-analysis Methods and Models with Applications in Evaluation of Cholesterol Lowering Drugs. Statistics in Medicine, 31, 3597-3616.
220. Ibrahim, J.G., Chu, H., and Chen, M.-H. (2012). Missing Data in Clinical Studies: Issues and Methods. Journal of Clinical Oncology, 30(26), 3297-3303.
221. Chen, R.C., Zhang, Y., Chen, M.-H., McMahon, E., Loffredo, M., McPherson, C.P., Nguyen, A.U., Nguyen, P.L., and D'Amico, A.V. (2012). Patient-Reported Quality of Life during Radiation Treatment for Localized Prostate Cancer: Results from a Prospective Phase II Trial. BJU International, 110(11), 1690-1695.
222. Martin, N.E., Chen, M.-H., Nguyen, P.L., Beard, C.J., Loffredo, M.J., Kantoff, P.W., and D'Amico, A.V. (2012). Biopsy Gleason score and the duration of testosterone suppression among men treated with external beam radiation and 6 months of combined androgen blockade. BJU International, 110 (9), 1252-1256.
223. Tseng, Y.D., Chen, M.-H., Beard, C.J., Martin, N.E., Orio, P.F., Loffredo, M., Renshaw, A.A., Choueiri, T.K., Hu, J.C., Kantoff, P.W., D'Amico, A.V., and Nguyen, P.L. (2012). Post-treatment prostate-specific antigen nadir is predictive of all-cause mortality: a reanalysis ofthe Dana-Farber Cancer Institute radiation with or without androgen deprivation therapy randomized trial. The Journal of Urology, 187(6), 2068-2073.
224. Westover, K., Chen, M.-H., Moul, J., Robertson, C., Polascik, T., Dosoretz, D., Katin, M., Salenius, S., D'Amico, A.V. (2012). Radical Prostatectomy vs. Radiation Therapy and Androgen Suppression Therapy in High Risk Prostate Cancer. BJU International, 110(8), 1116-1121.
225. Kishan, A.U., Chen, M.-H., Loffredo, M., Kim, D., Beard, C.J., Hurwitz, M.D., Martin, N.E., Orio, P.F., Kantoff, P.W., D'Amico, A.V., and Nguyen, P.L. (2012). Low Rate of Clinician-Scored Gynecomastia Induced by Six Months of Combined Androgen Blockade in a Randomized Trial: Implications for Prophylactic Breast Irradiation. Practical Radiation Oncology, 2(3), 172-178.
226. Ibrahim, J.G., Chen, M.-H., Xia, H.A., and Liu, T. (2012). Bayesian Meta-Experimental Design: Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes. Biometrics, 68(2), 578-586.
227. Zhao, Y., Chen, M.-H., Pei, B., Rowe, D., Shin, D.-G., Xie, W., Yu, F., and Kuo, L. (2012). A Bayesian Approach to Pathway Analysis by Integrating Gene-Gene Functional Directions and Microarray Data. Statistics in Biosciences, 4, 105-131. DOI 10.1007/s12561-011-9046-1.
228. Rosenberg, J.E., Chen, M.-H., Nguyen, P.L., Braccioforte, M.H., Moran, B.J., and D'Amico, A.V. (2012). Hormonal Therapy or External-Beam Radiation with Brachytherapy and the Risk of Death from Prostate Cancer in Men with Intermediate Risk Prostate Cancer. Clinical Genitourinary Cancer, 10(1), 21-25.
229. Wattson, D.A., Chen, M.-H., Moul, J.W., Moran, B.J., Dosoretz, D.E., Robertson, C.N., Polascik, T.J., Braccioforte, M.H., Salenius, S.A., and D'Amico, A.V. (2012). The Number of High Risk Factors and the Risk of Prostate Cancer-Specific Mortality after Brachytherapy: Implications for Treatment Selection. International Journal of Radiation Oncology, Biology, Physics, 82(5), e773-e779.
230. D'Amico, A.V., Chen, M.-H., de Castro, M., Loffredo, M., Lamb, D.S., Steigler, A., Kantoff, P.W., and Denham, J.W. (2012). Surrogate Endpoints for Prostate Cancer-Specific Mortality after Radiation and Androgen Suppression Therapy in Men with Localised or Locally Advanced Prostate Cancer: An Analysis of Two Randomised Trials. The Lancet Oncology, 13(2), 189-195.
231. Zeng, D., Chen, Q., Chen, M.-H., Ibrahim, J.G., and the Amgen Research Group (2012). Estimating Treatment Effects with Treatment Crossovers via Semi-Competing Risks Models: An Application to a Colorectal Cancer Study. Biometrika, 99(1), 167-184.
232. Nguyen, P.L., Chen, M.-H., Hoffman, K.E., Chen, R.C., Hu, J.C., Bennett, C.L., Kattan, M.W., Sartor, O., Stein, K., and D'Amico, A.V. (2012). Cardiovascular Comorbidity and Treatment Regret in Men with Recurrent Prostate Cancer. BJU International, 110(2), 201-205.
233. Kang, J., Chen, M.-H., Zhang, Y., Moran, B.J., Dosoretz, D.E., Katin, M.J., Braccioforte, M.H., Salenius, S.A., and D'Amico, A.V. (2012). Type of Diabetes Mellitus and the Odds of Gleason Score 8 to 10 Prostate Cancer. International Journal of Radiation Oncology, Biology, Physics, 82(3), e463-e467.
234. Park, J.J., Chen, M.-H., Loffredo, M., and D'Amico, A.V. (2012). Prostate-Specific Antigen Velocity before and after the Elimination of Factors That Can Confound the Prostate-Specific Antigen Level. International Journal of Radiation Oncology, Biology, Physics, 82(3), 1217-1221.
235. Nguyen, P.L., Chen, M.-H., Beckman, J.A., Beard, C.J., Martin, N.E., Choueiri, T.K., Hu, J.C., Hoffman, K.E., Dosoretz, D.E., Moran, B.J., Salenius, S.A., Braccioforte, M.H., Kantoff, P.W., D'Amico, A.V., and Ennis, R.D. (2012). Inference of Androgen Deprivation Therapy on All-cause Mortality in Men with High-risk Prostate Cancer and a History of Congestive Heart Failure or Myocardial Infarction. International Journal of Radiation Oncology, Biology, Physics, 82(4), 1411-1416. doi:10.1016/j.ijrobp.2011.04.067.
236. D'Amico, A.V., Chen, M.-H., Crook, J., , Armstrong, J.G., Malone, S., Steigler, A., Dunne, M., and Denham, J.W. (2011). Duration of Short-Course Androgen Suppression Therapy and the Risk of Death as a Result of Prostate Cancer. Journal of Clinical Oncology, 29(35), 4682-4687.
237. Mitin, T., Chen, M.-H., Zhang, Y., Moran, B.J., Dosoretz, D.E., Katin, M.J., Braccioforte, M.H., Salenius, S.A., and D'Amico, A.V. (2011). Diabetes Mellitus, Race and the Odds of High grade Prostate Cancer in Men Treated with Radiation Therapy. Journal of Urology, 186(6), 2233-2237.
238. Yao, H., Chen, M.-H., and Qiu, C. (2011). Bayesian Modeling and Inference for Meta Data with Applications in Efficacy Evaluation of an Allergic Rhinitis Drug. Journal of Biopharmaceutical Statistics, 21(5), 992-1005.
239. D'Amico, A.V., Chen, M.-H., Dosoretz, D.E., Katin, M., Salenius, S.A., Ross, R.H., and Goldhaber, S.Z. (2011). Coronary Artery Revascularization and the Risk of Death in Men with Prostate Cancer. The Journal of Urology, 186(3), 898-902.
240. Winkfield, K.M., Chen, M.-H., Dosoretz, D.E., Salenius, S.A., Katin, M., Ross, R.H., and D'Amico, A.V. (2011). Race and Survival Following Brachytherapy-based Treatment for Men with Localized or Locally Advanced Adenocarcinoma of the Prostate. International Journal of Radiation Oncology, Biology, Physics, 81(4), e345-350.
241. Hattangadi, J.A., Chen, M.-H., Braccioforte, M.-H., and D'Amico, A.V. (2011). Predictors of the Use of Supplemental Androgen Suppression Therapy and External Beam Radiation in Men with High-Risk Prostate Cancer Undergoing Brachytherapy in Community Practice. Brachytherapy, 10(5), 369-375.
242. Cotter, S.E., Chen, M.-H., Moul, J.W., Lee, W.R., Koontz, B.F., Anscher, M.S., Robertson, C.N., Walther, P.J., Polascik, T.J., and D'Amico, A.V. (2011). Salvage Radiation in Men Following PSA Failure and the Risk of Death. Cancer, 117(11), 3925-3932.
243. Arvold, N.D., Chen, M.-H., Moul, J.W., Moran, B.J., Dosoretz, D.E., Ba\~{n}ez, L.L., Katin, M.J., Braccioforte, M.H., and D'Amico, A.V. (2011). Risk of Death from Prostate Cancer After Radical Prostatectomy or Brachytherapy in Men with Low- or Intermediate-Risk Disease. The Journal of Urology, 186(1), 91-96.
244. Chen, M.-H., Ibrahim, J.G., Lam, P., Yu, A., and Zhang, Y. (2011). Bayesian Design of Non-Inferiority Trials for Medical Devices Using Historical Data. Biometrics, 67, 1163-1170. DOI: 10.1111/j.1541-0420.2011.01561.x.
245. Kim, S., Chen, M.-H., and Dey, D.K. (2011). A New Threshold Regression Model for Survival Data with a Cure Fraction. Lifetime Data Analysis, 17, 101-122.
246. Crawford, E.D., Grubb III, R., Black, A., Andriole, Jr, G.L., Chen, M.-H., Izmirlian, G., Berg, C.D., and D'Amico, A.V. (2011). Comorbidity and Mortality Results from a Randomized Prostate Cancer Screening Trial. Journal of Clinical Oncology, 29(4), 355-361.
247. Fan, Y., Wu, R., Chen, M.-H., Kuo, L. and Lewis, P.O. (2011). Choosing among Partition Models in Bayesian Phylogenetics. Molecular Biology and Evolution, 28(1), 523-532.
248. Xie, W., Lewis, P.O., Fan, Y., Kuo, L., and Chen, M.-H. (2011). Improving Marginal Likelihood Estimation for Bayesian Phylogenetic Model Selection. Systematic Biology, 60(2), 150-160.
249. Chen, M.-H. and Gustafson, P. (2011). Bayesian Methods in Survival Analysis. Lifetime Data Analysis, 17, 1-2.
250. Nguyen, P.L., Chen, M.-H., Goldhaber, S.Z., Martin, N.E., Beard, C.J., Dosoretz, D.E., Katin, M.J., Ross, R., Salenius, S.A., and D'Amico, A.V. (2011). Coronary Revascularization and Mortality in Men with Congestive Heart Failure or Prior Myocardial Infarction Who Receive Androgen Deprivation. Cancer, 117(2), 406-413.
251. Yu, F., Chen, M.-H., Kuo, L., Huang, P., and Yang, W. (2011). Bayesian Hierarchical Modeling and Selection of Differentially Expressed Genes for the EST Data. Biometrics, 67, 142-150.
252. Das, S., Chen, M.-H., Warren, N., and Hodgson, M. (2011). Do Associations Between Employee Self-Reported Organisational Assessments and Attitudinal Outcomes Change Over Time? An Analysis of Four Veterans Health Administration Surveys Using Structural Equation Modelling. Health Economics, 20(12) . 1507-1522.
253. Hoffman, K.E., Nguyen, P. L., Chen, M.-H., Chen, R. C., Choueiri, T. K., Hu, J. C., Kuban, D. A., and D'Amico, A.V. (2011). Recommendations for post-prostatectomy radiation therapy in the United States before and after the presentation of randomized trials. The Journal of Urology, 185(1), 116-120.
254. Nguyen, P.L., Chen, M.-H., Choueiri, T.K., Hoffman, K.E., Hu, J.C., Martin, N.E., Beard, C.J., Dosoretz, D.E., Moran, B.J., Katin, M.J., Braccioforte, M.H., Ross, R., Salenius, S.A., Kantoff, P.W., and D'Amico, A.V. (2011). Risk of All-Cause and Prostate Cancer-Specific Mortality After Brachytherapy in Men with Small Prostate Size. International Journal of Radiation Oncology, Biology, Physics, 79(5), 1318-1322.
255. D'Amico, A.V., Chen, M.-H., Sun, L., Lee, W.R., Mouraviev, V., Robertson, C.N., Walther, P.J., Polascik, T.J., Albala, D.M., and Moul, J.W. (2010). Adjuvant versus Salvage Radiation Therapy for Prostate Cancer and the Risk of Death. BJU International, 106(11), 1618-1622.
256. Chen, M.-H., Kim, S., Kuo, L., and Xie, W. (2010). Bayesian Choice of Links and Computation for Binary Response Data. In Frontiers of Statistical Decision Making and Bayesian Analysis (eds. M.-H., Chen, D.K. Dey, P. Mueller, D. Sun, and K. Ye). New York: Springer, pp. 451-466.
257. Yu, F., Chen, M.-H., and Kuo, L. (2010). Bayesian Methods for Detecting Differentially Expressed Genes. In Bayesian Modeling in Bioinformatics (eds., D.K. Dey, S. Ghosh, and B.K. Mallick), Boca Raton, FL: Chapman & Hall/CRC, pp. 365-386.
258. Nguyen, P.L., Chen, M.-H., Beard, C.J., Suh, W.W., Renshaw, A.A., Loffredo, M., McMahon, E., Kantoff, P.W., and D'Amico, A.V. (2010). Radiation With or Without 6 Months of Androgen Suppression Therapy in Intermediate and High-Risk Clinically Localized Prostate Cancer: A Post-Randomization Analysis by Risk Group. International Journal of Radiation Oncology, Biology, Physics, 77(4), 1046-1052.
259. Dosoretz, A.M., Chen, M.-H., Salenius, S.A., Ross, R.H., Dosoretz, D.E., Katin, M.J., Mantz, C., Nakfoor, B.M., and D'Amico, A.V. (2010). Mortality in Men with Localized Prostate Cancer Treated with Brachytherapy with or without Neoadjuvant Hormonal Therapy. Cancer, 116(4), 837-842.
260. Nguyen, P.L., Chen, M.-H., Beard, C.J., Suh, W.W., Choueiri, T.K., Efstathiou, J.A., Hoffman, K.E., Loffredo, M., Kantoff, P.W., and D'Amico, A.V. (2010). Comorbidity, Body Mass Index, and Age and the Risk of Nonprostate-Cancer-Specific Mortality after a Postradiation Prostate-Specific Antigen Recurrence. Cancer, 116(3), 610-615.
261. Hayes, J.H., Chen, M.-H., Moran, B.J., Braccioforte, M.H., Dosoretz, D.E., Salenius, S.A., Katin, M.J., Ross, R.H., and D'Amico, A.V. (2010). Androgen Suppression Therapy for Prostate Cancer and the Risk of Death in Men with a History of Myocardial Infarction or Stroke. BJU International, 106(7), 979-985.
262. Williams, S.B., Chen, M.-H., D'Amico, A.V., Weinberg, A.C., Kacker, R., Hirsch, M.S., Richie, J.P., and Hu, J.C. (2010). Radical Retropubic Prostatectomy and Robotic Assisted Laparoscopic Prostatectomy: Likelihood of Positive Surgical Margin(s). Urology, 76(5), 1097-1101.
263. Dest, W.M., Guillard, K., Rackliffe, S.L., Chen, M.-H., and Wang, X. (2010). Putting Green Speeds: A Reality Check! Online. Applied Turfgrass Science. doi:10.1094/ATS-2010-0216-01-RS.
264. Choueiri, T.K., Chen, M.-H., D'Amico, A.V., Sun, L., Nguyen, P.L., Hayes, J.H., Robertson, C.N., Walther, P.J., Polascik, T.J., Albala, D.M., and Moul, J.W. (2010). Impact of Postoperative Prostate-Specific Antigen Disease Recurrence and the Use of Salvage Therapy on the Risk of Death. Cancer, 116(8), 1887-1892.
265. Hoffman, K.E., Chen, M.-H., Moran, B.J., Braccioforte, M.H., Dosoretz, D.E., Salenius, S.A., Katin, M.J., Ross, R.H., and Anthony V. D'Amico, A.V. (2010). Prostate Cancer-Specific Mortality and the Extent of Therapy in Healthy Elderly Men with High-Risk Prostate Cancer. Cancer, 116(11), 2590-2595.
266. Cheung, A.K., Chen, M.-H., Moran, B.J., Braccioforte, M.H., Dosoretz, D.E., Salenius, S.A., Katin, M.J., Ross, R.H., D'Amico, A.V. (2010). The Use of Supplemental External Beam Radiotherapy in Men with Low-Risk Prostate Cancer Undergoing Brachytherapy Before and After the 1999 American Brachytherapy Society Guideline Statement. Brachytherapy, 9(2), 145-150.
267. D'Amico, A.V., Braccioforte, M.H., Moran, B.J., and Chen, M.-H. (2010). Causes of Death in Men with Prevalent Diabetes and Newly Diagnosed High- versus Favorable-risk Prostate Cancer. International Journal of Radiation Oncology, Biology, Physics, 77(5), 1329-1337.
268. Nanda, A., Chen, M.-H., Moran, B.J., Braccioforte, M.H., Dosoretz, D., Salenius, S.A., Katin, M.J., Ross, R.H., and D'Amico, A.V. (2010). Total Androgen Blockade versus a Luteinizing Hormone-Releasing Hormone Agonist Alone in Men with High-Risk Prostate Cancer Treated with Radiation Therapy. International Journal of Radiation Oncology, Biology, Physics, 76(5). 1439-1444.
269. Nguyen, P.L., Chen, M.-H., Renshaw, A.A., Loffredo, M., Kantoff, P.W., and D'Amico, A.V. (2010). Survival Following Radiation and Androgen Suppression Therapy for Prostate Cancer in Healthy Older Men: Implications for Screening Recommendations. International Journal of Radiation Oncology, Biology, Physics, 76(2), 337-341.
270. D'Amico, A.V., Braccioforte, M., Moran, B.S., and Chen, M.-H. (2010). Luteinizing-Hormone Releasing Hormone Therapy for Prostate Cancer and the Risk of Death from Alzheimer's Disease. Alzheimer Disease & Associated Disorders - An International Journal, 24(1), 85-89.
271. Nanda, A., Chen, M.-H., Moran, B.J., Braccioforte, M.H., Dosoretz, D., Salenius, S.A., Katin, M.J., Ross, R.H., and D'Amico, A.V. (2010). Predictors of Prostate Cancer-Specific Mortality in Elderly Men with Intermediate-Risk Prostate Cancer Treated with Brachytherapy with or without External Beam Radiation Therapy. International Journal of Radiation Oncology, Biology, Physics, 77(1), 147-152.
272. Nanda, A., Chen, M.-H., Braccioforte, M.H., Moran, B.J., and D'Amico, A.V. (2009). Hormonal Therapy Use for Prostate Cancer and Mortality in Men with Coronary Artery Disease-Induced Congestive Heart Failure or Myocardial Infarction. The Journal of the American Medical Association, 302(8), 866-873.
273. Huang, P., Chen, M.-H., and Sinha, D. (2009). A Latent Model Approach to Define Event Onset Time in the Presence of Measurement Error. Statistics and Its Interface, 2, 425-435
274. Wo, J.Y., Chen, M.-H., Nguyen, P.L., Renshaw, A.A., Loffredo, M.J., Kantoff, P.W., and D'Amico, A.V. (2009). Evaluating the Combined Effect of Comorbidity and Prostate-Specific Antigen Kinetics on the Risk of Death in Men Following Prostate-Specific Antigen Recurrence. Journal of Clinical Oncology, 27(35), 6000-6005.
275. D'Amico, A.V. and Chen, M.-H. (2009). Pretreatment Prostate-Specific Antigen Velocity and the Risk of Death From Prostate Cancer in the Individual with Low-Risk Prostate Cancer. Journal of Clinical Oncology, 27(22), 3575-3576.
276. Chen, M.-H. and Kim, S. (2009). Comments on Article, ``Bayesian Generalized Method of Moments", by G. Yin. Bayesian Analysis 4, 209-212.
277. Chen, M.-H. and Kim, S. (2009). Cure Rate Models with Applications to Melanoma and Prostate Cancer Data. In Design and Analysis of Clinical Trials with Time-to-Event Endpoints, Eds. K.E. Peace, Boca Raton, FL: CRC Press/Chapman & Hall, pp. 349-370.
278. Chen, M.-H., Ibrahim, J.G. and Shao, Q.-M. (2009). Maximum Likelihood Inference for the Cox Regression Model with Applications to Missing Covariates. Journal of Multivariate Analysis, 100, 2018-2030.
279. Nguyen, P.L., Chen, M.-H., Hoffman, K.E., Katz, M.S., and D'Amico, A.V. (2009). Predicting the Risk of Pelvic Node Involvement Among Men With Prostate Cancer in the Contemporary Era. International Journal of Radiation Oncology, Biology, Physics, 74(1), 104-109.
280. D'Amico, A.V., Moran, B.J., Braccioforte, M., Dosoretz, D., Salenius, S.A., Katin, M.J., Ross, R.H., and Chen, M.-H. (2009). Risk of Death from Prostate Cancer Following Brachytherapy Alone or with Radiation, Androgen Suppression Therapy or Both in Men with High-risk Disease. Journal of Clinical Oncology, 27(24), 3923-3928.
281. D'Amico, A.V. and Chen, M.-H. (2009). Pre-Treatment Prostate-Specific Antigen Velocity and the Risk of Death from Prostate Cancer in the Individual with ``Low-Risk" Prostate Cancer. Journal of Clinical Oncology, 27(22), 3575-3576.
282. Nanda, A., Chen, M.-H., and D'Amico, A.V. (2009). Mathematical Rigor Is Necessary, But for Men With Prostate Cancer, Clinical Relevance Is the Priority. Journal of Clinical Oncology, 27(10), 1728-1729.
283. Kim, S., Xi, Y., and Chen, M.-H. (2009). A New Latent Cure Rate Marker Model for Survival Data. The Annals of Applied Statistics 3, 1124-1146.
284. Kim, S., Das, S., Chen, M.-H., and Warren, N. (2009). Bayesian Structural Equations Modeling for Ordinal Response Data with Missing Responses and Missing Covariates. Communications in Statistics - Theory and Methods, 38 , 2748-2768.
285. D'Amico, A.V., Chen, M.-H., Renshaw, A.A., Loffredo, M., and Kantoff, P.W. (2009). Interval to Testosterone Recovery after Hormonal Therapy for Prostate Cancer and the Risk of Death. International Journal of Radiation Oncology, Biology, Physics, 75(1), 10-15.
286. Chen, R.C., Sadetsky, N., Chen, M.-H., Carroll, P.R., and D'Amico, A.V. (2009). Maximum versus Mono Androgen Blockade and the Risk of Recurrence in Men with Localized Prostate Cancer Undergoing Brachytherapy. International Journal of Radiation Oncology, Biology, Physics, 75(1), 36-39.
287. Nanda, A. Chen, M.-H., Renshaw, A.A., and D'Amico, A.V. (2009). Gleason Pattern 5 Prostate Cancer: Further Stratification of Patients with High-Risk Disease and Implications for Future Randomized Trials. International Journal of Radiation Oncology, Biology, Physics, 74 (5), 1419-1423.
288. Nguyen, P.L., Chen, M.-H., Catalona, W.J., Moul, J.W., Sun, L., and D'Amico, A.V. (2009). Predicting Prostate Cancer Mortality Among Men with Intermediate to High-Risk Disease and Multiple Unfavorable Risk Factors. International Journal of Radiation Oncology, Biology, Physics, 73(3), 659-664.
289. Chen, M.-H. and Kim, S. (2008). The Bayes Factor Versus Other Model Selection Criteria for the Selection of Constrained Models. In Bayesian Evaluation of Informative Hypotheses, Eds. H. Hoijtink, I. Klugkist, and P. A. Boelen, New York: Springer, pp. 155-180.
290. Ibrahim, J.G., Chen, M.-H., and Kim, S. (2008). Bayesian Variable Selection for Cox Regression Models with Missing Covariates. Lifetime Data Analysis, 14 , 496-520.
291. Chen, M.-H., Ibrahim, J.G., and Kim, S. (2008). Properties and Implementation of Jeffreys's Prior in Binomial Regression Models. Journal of the American Statistical Association, 103, 1659-1664.
292. Chen, M.-H., Huang, L., Ibrahim, J.G., and Kim, S. (2008). Bayesian Variable Selection and Computation for Generalized Linear Models with Conjugate Priors. Bayesian Analysis, 3, 585-614.
293. Nguyen, P.L., Chen, M.-H., Catalona, W.J., Alexander, B.M., Roeh, K.A., Loeb, S., and D'Amico, A.V. (2008). Biochemical Recurrence Following Radical Prostatectomy for Prevalent vs. Incident Cases of Prostate Cancer: Implications for Management. Cancer, 113(11), 3146-3152.
294. D'Amico, A.V., Chen, M.-H., Renshaw, A.A., Loffredo, M., and Kantoff, P.W. (2008). Causes of Death in Men Undergoing Androgen Suppression Therapy for Newly Diagnosed Localized or Recurrent Prostate Cancer. Cancer, 113 (12), 3290-3297.
295. Hoffman, K.E., Chen, M.-H., Punglia, R.S., Beard, C.J., and D'Amico, A.V. (2008). Influence of Year of Diagnosis, Patient Age, and Sociodemographic Status on Recommending Adjuvant Radiation Treatment for Stage I Testicular Seminoma in the United States. Journal of Clinical Oncology, 26(24), 3937-3942.
296. Martin, N.E., Chen, M.-H., Catalona, W.J., Loeb, S., Roehl, K.A., and D'Amico, A.V. (2008). The influence of Serial Prostate-Specific Antigen (PSA) Screening on the PSA Velocity at Diagnosis. Cancer, 113(4), 717-722.
297. D'Amico, A.V., Chen, M.-H., Renshaw, A.A., Loffredo, B., and Kantoff, P.W. (2008). Risk of Prostate Cancer Recurrence in Men Treated with Radiation Alone or in Conjunction with Combined or less than Combined Androgen Suppression Therapy. Journal of Clinical Oncology, 26(18), 2979-2983.
298. Huang, L., Chen, M.-H., Yu, F., Neal, P.R., and Anderson, G.J. (2008). On Modeling Repeated Binary Responses and Time-Dependent Missing Covariates. Journal of Agricultural, Biological and Environmental Statistics, 13(3) , 270-293.
299. Cheng, S., Xi, Y., and Chen, M.-H. (2008). A New Mixture Model for Misclassification with Applications for Survey Data. Sociological Methods and Research, 37, 75-104.
300. Kim, S., Chen, M.-H., and Dey, D.K. (2008). Flexible Generalized t-Link Models for Binary Response Data. Biometrika, 95(1), 93-106.
301. Chung, C.S., Chen, M.-H., Cullen, J., McLeod, D., Carroll, P., and D'Amico, A.V. (2008). Time to Prostate-Specific Antigen Nadir after Androgen Suppression Therapy for Postoperative or Postradiation PSA Failure and Risk of Prostate Cancer-Specific Mortality. Urology, 71(1), 136-140.
302. D'Amico, A.V., Chen, M.-H., Renshaw, A.A., Loffredo, M., and Kantoff, P.W. (2008). Androgen Suppression and Radiation vs Radiation alone for Prostate Cancer: A Randomized Trial. The Journal of the American Medical Association, 299 (3), 289-295.
303. Yu, F., Chen, M.-H., and Kuo, L. (2008). Detecting Differentially Expressed Genes Using Calibrated Bayes Factors. Statistica Sinica, 18 , 783-802.
304. Chen, Q., Ibrahim, J.G., Chen, M.-H., and Senchaudhuri, P. (2008). Theory and Inference for Regression Models with Missing Response and Covariates. Journal of Multivariate Analysis, 99 , 1302-1331.
305. Das, S., Chen, M.-H., Kim, S., and Warren, N. (2008). A Bayesian Structural Equations Model for Multilevel Data with Missing Responses and Missing Covariates. Bayesian Analysis, 3 , 197-224.
306. Chen, M.-H., Ibrahim, J.G., and Chi, Y.-Y. (2008). A New Class of Mixture Models for Differential Gene Expression in DNA Microarray Data. Journal of Statistical Planning and Inference, 138, 387-404. DOI: 10.1016/j.jspi.2007.06.007.
307. D'Amico, A.V., Kantoff, P.W., and Chen, M.-H. (2007). Aspirin and Hormone Therapy for Prostate Cancer. New England Journal of Medicine, 357(26), 2737-2738 (Correspondence).
308. Patel, A.A., Chen, M.-H., Renshaw, A.A., and D'Amico, A.V. (2007). PSA Failure Following Definitive Treatment of Prostate Cancer Having Biopsy Gleason Score 7 with Tertiary Grade 5. The Journal of the American Medical Association, 298(13), 1533-1538.
309. Tsai, H.K., D'Amico, A.V., Sadetsky, N., Chen, M.-H., and Carroll, P.R. (2007). Androgen Deprivation Therapy for Localized Prostate Cancer and the Risk of Cardiovascular Mortality. Journal of the National Cancer Institute, 99, 1516-1524.
310. Alexander, B.M., Chen, M.-H., Carroll, P., and D'Amico, A.V. (2007). Prostate-Specific Antigen Level at Initiation of Hormonal Therapy after Prostate-Specific Antigen Failure Following Prostatectomy or Radiotherapy and Therapeutic Response. Urology, 70(2), 320-323.
311. Nguyen, P.L., Chen, M.-H., D'Amico, A.V., Tempany, C.M., Steele, G.S., Albert, M., Cormack, R., Carr-Locke, D.L., Bleday, R., and Suh, W.W. (2007). Magnetic Resonance Image-Guided Salvage Brachytherapy after Radiation in Select Men Who Initially Presented with Favorable-Risk Prostate Cancer: A Prospective Phase II Study. Cancer, 110(7), 1485-1492.
312. Nguyen, P.L., Chen, M.-H., Renshaw, A.A., Sussman, B., and D'Amico, A.V. (2007). Effect of Definition of Preradiotherapy Prostate-Specific Antigen Velocity on Its Association with Prostate Cancer-Specific Mortality and All-Cause Mortality. Urology, 70(2), 288-293.
313. D'Amico, A.V., Renshaw, A.A., Loffredo, B., and Chen, M.-H. (2007). Duration of Testosterone Suppression and the Risk of Death from Prostate Cancer in Men Treated Using Radiation and 6 Months of Hormonal Therapy. Cancer, 110(8), 1723-1728.
314. D'Amico, A.V., Denham, J.W., Crook, J., Chen, M.-H., Goldhaber, S.Z., Lamb, D.S., Tai, K.-H., Malone, S., Ludgate, C., Steigler, A., and Kantoff, P.W. (2007). The Influence of Androgen Suppression Therapy for Prostate Cancer on the Frequency and Timing of a Fatal Myocardial Infarction. Journal of Clinical Oncology, 25(17), 2420-2425.
315. D'Amico, A.V., Chen, M.-H., Catalona, W.J., Sun, L., Roehl, K.A., and Moul, J.W. (2007). Prostate Cancer Specific Mortality Following Radical Prostatectomy or External Beam Radiation Therapy in Men with One or More High-Risk Factors. Cancer, 110(1), 56-61.
316. D'Amico, A.V., Denham, J.W., Bolla, M., Collette, L., Lamb, D.S., Tai, K.-H., Steigler, A., and Chen, M.-H. (2007). Short- versus Long-term Androgen Suppression plus External Beam Radiation Therapy and Survival in Men of Advanced Age with Node Negative High-Risk Adenocarcinoma of the Prostate. Cancer, 109(10), 2004-2010.
317. Krejcarek, S.C., Chen, M.-H., Renshaw, A.A., Loffredo, M.J., Sussman, B., and D'Amico, A.V. (2007). Prediagnostic Prostate-Specific Antigen Velocity and Probability of Detecting High-Grade Prostate Cancer. Urology, 69(3), 515-519.
318. Efstathiou, J.A., Chen, M.-H., Renshaw, A.A., Loffredo, M.J., and D'Amico, A.V. (2007). The Influence of Body Mass Index on PSA Failure following Androgen Suppression and Radiation Therapy for Localized Prostate Cancer. Cancer, 109(8), 1493-1498.
319. Balboni, T.A., Chen, M.-H., Harris, J.R., Recht, A., Stevenson, M.A., and D'Amico, A.V. (2007). Academic Career Selection and Retention in Radiation Oncology: The Joint Center for Radiation Therapy Experience. International Journal of Radiation Oncology, Biology, Physics, 68(1), 183-186.
320. Banerjee, T., Chen, M.-H., Dey, D.K., and Sungduk Kim (2007). Bayesian Analysis of Generalized Odds-Rate Hazards Models for Survival Data. Lifetime Data Analysis, 13(2), 241-260.
321. D'Amico, A.V., McLeod, D.G., Carroll, P.R., Cullen, J., and Chen, M.-H. (2007). Time to an Undetectable Prostate-Specific Antigen (PSA) after Androgen Suppression Therapy for Postoperative or Postradiation PSA Recurrence and Prostate Cancer-Specific Mortality. Cancer, 109(7), 1290-1295.
322. Kim, S., Chen, M.-H., Dey, D.K., and Gamerman, D. (2007). Bayesian Dynamic Models for Survival Data with a Cure Fraction. Lifetime Data Analysis, 13(1), 17-35.
323. D'Amico, A.V., Chen, M.-H., Renshaw, A.A., Sussman, B., Roehl, K.A., and Catalona, W.J. (2006). Identifying Men Diagnosed With Clinically Localized Prostate Cancer Who are at High Risk for Death From Prostate Cancer. The Journal of Urology, 176(6S), S11-S15. pdf file
324. Chen, M.-H., Ibrahim, J.G. and Shao, Q.-M. (2006). Posterior Propriety and Computation for the Cox Regression Model with Applications to Missing Covariates. Biometrika, 93, 791-807.
325. Tsai, H.K., Chen, M.-H., McLeod, D.G., Carroll, P.R., Richie, J.P., and Anthony V. D'Amico (2006). Cancer-Specific Mortality after Radiation Therapy with Short-Course Hormonal Therapy or Radical Prostatectomy in Men with Localized, Intermediate-Risk to High-Risk Prostate Cancer. Cancer, 107(11), 2597-2603.
326. D'Amico, A.V., Loffredo, M., Renshaw, A.A., Loffredo, B., and Chen, M.-H. (2006). Six-Month Androgen Suppression Plus Radiation Therapy Compared With Radiation Therapy Alone for Men With Prostate Cancer and a Rapidly Increasing Pretreatment Prostate-Specific Antigen Level. Journal of Clinical Oncology, 24(25), 4190-4195.
327. Petit, J.H., Chen, M.-H., Loffredo, M., Sussman, B., Renshaw, A.A., and D'Amico, A.V. (2006). Prostate-Specific Antigen Recurrence and Mortality Following Conventional Dose Radiation Therapy in Select Men with Low-risk Prostate Cancer. Cancer, 107(9), 2180-2185.
328. Rodrigues, N.A., Chen, M.-H., Catalona, W.J., Roehl, K.A., Richie, J.P., and D'Amico, A.V. (2006). Predictors of Mortality after Androgen-Deprivation Therapy in Patients with Rapidly Rising Prostate-Specific Antigen Levels after Local Therapy for Prostate Cancer. Cancer, 107(3), 514-520.
329. Efstathiou, J.A., Chen, M.-H., Catalona, W.J., McLeod, D.G., Carroll, P.R., Moul, J.W., Roehl, K.A., and D'Amico, A.V. (2006). Prostate-Specific Antigen-based Serial Screening May Decrease Prostate Cancer-Specific Mortality. Urology, 68(2), 342-347.
330. D'Amico, A.V., Kantoff, P., Loffredo, M., Renshaw, A.A., Loffredo, B., and Chen, M.-H. (2006). Predictors of Mortality after Prostate-Specific Antigen Failure. International Journal of Radiation Oncology, Biology, Physics, 65 (3), 656-660.
331. Chen, M.-H. and Ibrahim, J.G. (2006). The Relationship Between the Power Prior and Hierarchical Models. Bayesian Analysis, 1, 551-574.
332. Rozhansky, F., Chen, M.-H., Cox, M.C., Dahut, W., Figg, W.D., and D'Amico, A.V. (2006). Prostate-Specific Antigen Velocity and Survival for Patients with Hormone-Refractory Metastatic Prostate Carcinoma. Cancer, 106(1), 63-67.
333. Galper, S.L., Chen, M.-H., Catalona, W.J., Roehl, K.A., Richie, J.P., and D'Amico, A.V. (2006). Evidence to Support a Continued Stage Migration and Decrease in Prostate Cancer-Specific Mortality. The Journal of Urology, 175(3), 907-912.
334. Beard, C., Chen, M.-H., Cote, K., Loffredo, M., Renshaw, A., Hurwitz, M., and D'Amico, A.V. (2005). Pretreatment Predictors of Posttreatment PSA Doubling Times for Patients Undergoing Three-Dimensional Conformal Radiotherapy for Clinically Localized Prostate Cancer. Urology, 66(5), 1020-1023.
335. Stewart, A.J., Scher, H.I., Chen, M.-H., McLeod, D.G., Carroll, P.R., Moul, J.W., and D'Amico, A.V. (2005). Prostate-Specific Antigen Nadir and Cancer-Specific Mortality Following Hormonal Therapy For Prostate-Specific Antigen Failure And The Risk Of Cancer-Specific Mortality. Journal of Clinical Oncology, 23(27), 6556-6560.
336. Zhou, P., Chen, M.-H., McLeod, D., Carroll, P.R., Moul, J.W., and D'Amico, A.V. (2005). Predictors of Prostate Cancer-Specific Mortality After Radical Prostatectomy or Radiation Therapy. Journal of Clinical Oncology, 23(28), 6992-6998.
337. D'Amico, A.V., Chen, M.-H., Roehl, K.A., and Catalona, W.J. (2005). Identifying Patients at Risk for Significant versus Clinically Insignificant Postoperative Prostate-specific Antigen Failure. Journal of Clinical Oncology, 23(22), 4975-4979.
338. D'Amico, A.V., Renshaw, A.A., Sussman, B., and Chen, M.-H. (2005). Pre-treatment PSA Velocity and the Risk of Death from Prostate Cancer Following External Beam Radiation Therapy. The Journal of the American Medical Association, 294, 440-447.
339. D'Amico, A.V., Moul, J., Carroll, P.R., Sun, L., Lubeck, D., and Chen, M.-H. (2005). Surrogate End Point for Prostate Cancer Specific Mortality for Patients with Nonmetastatic Hormone Refractory Prostate Cancer. The Journal of Urology, 173(5), 1572-1576.
340. Woel, R., Beard, C., Chen, M.-H., Hurwitz, M., Loffredo, M., McMahon, E., Ching, J., Lopes, L., and D'Amico, A.V. (2005). Acute Gastrointestinal, Genitourinary, and Dermatological Toxicity during Dose-escalated 3D-conformal Radiation Therapy (3DCRT) Using an Intrarectal Balloon for Prostate Gland Localization and Immobilization. International Journal of Radiation Oncology, Biology, Physics, 62, 392-396.
341. Dvorak, T., Chen, M.-H., Renshaw, A.A., Loffredo, M., Richie, J.P., and D'Amico, A.V. (2005). Maximal Tumor Diameter and the Risk of PSA Failure in Men with Specimen-Confined Prostate Cancer. Urology, 66(5), 1024-1028.
342. Chen, M.-H. (2005). Bayesian Computation: From Posterior Densities to Bayes Factors, Marginal Likelihoods, and Posterior Model Probabilities. In Bayesian Thinking, Modeling and Computation, Handbook of Statistics, 25, Eds. D.K. Dey and C.R. Rao, 437-457.
343. Chen, M.-H. (2005). Computing Marginal Likelihoods from A Single MCMC Output. Statistica Neerlandica. 59, 16-29.
344. Huang, L., Chen, M.-H., and Ibrahim, J.G. (2005). Bayesian Analysis for Generalized Linear Models with Nonignorably Missing Covariates. Biometrics, 61, 767-780.
345. Ibrahim, J.G., Chen, M.-H., Lipsitz, S.R., and Herring, A.H. (2005). Missing Data Methods in Regression Models. Journal of the American Statistical Association, 100, 332-346.
346. Gonzalo Garcia-Donato, G. and Chen, M.-H. (2005). Calibrating Bayes Factor Under Prior Predictive Distributions. Statistica Sinica, 15, 359-380.
347. Chen, M.-H., Ibrahim, J.G., and Sinha, D. (2004). A New Joint Model for Longitudinal and Survival Data with a Cure Fraction. Journal of Multivariate Analysis, 91, 18-34.
348. Chen, M.-H. (2004). Skewed Link Models for Categorical Response Data. In Skew-Elliptical Distributions and Their Applications: A Journey Beyond Normality, Genton, M. G., Ed., Chapman & Hall/CRC, Boca Raton, FL, 131-151.
349. D'Amico, A.V., Renshaw, A.A., Cote, K., Hurwitz, M., Beard, C., Loffredo, M., and Chen, M.-H. (2004). The Impact of the Percent of Positive Prostate Biopsies on Prostate Cancer-Specific Mortality for Patients with Low or Favorable Intermediate Risk Disease. Journal of Clinical Oncology, 22, 3726-3732.
350. D'Amico, A.V., Chen, M.-H., Roehl, K.A., and Catalona, W.J. (2004). The Preoperative PSA Velocity and the Risk of Death From Prostate Cancer After Radical Prostatectomy. New England Journal of Medicine 351, 125-135.
351. D'Amico, A.V., Moul, J.W., Carroll, P.R., Cote, K., Sun, L. Lubeck, D., Renshaw, A.A., Loffredo, M., and Chen, M.-H. (2004). Intermediate End Point for Prostate Cancer-Specific Mortality Following Hormonal Therapy for Prostate-Specific Antigen Failure. Journal of the National Cancer Institute, 96, 509-515. pdf file
352. Chen, M.-H., Ibrahim, J.G., and Shao, Q.-M. (2004). On Propriety of the Posterior Distribution and Existence of the Maximum Likelihood Estimator for Regression models with Covariates Missing at Random. Journal of the American Statistical Association, 99, 421-438
353. Chen, M.-H., Dey, D.K., and Ibrahim, J.G. (2004). Bayesian Criterion Based Model Assessment for Categorical Data. Biometrika, 91, 45-63.
354. Ibrahim, J.G., Chen, M.-H., and Sinha, D. (2004). Bayesian Methods for Joint Modelling of Longitudinal and Survival Data with Applications to Cancer Vaccine Studies. Statistica Sinica, 14, 863-883.
355. Beard, C.J., Chen, M.-H., Cote, K., Loffredo, M., Renshaw, A.A., Hurwitz, M., and D'Amico, A.V. (2004). Perineural Invasion Is Associated with Increased Relapse After External Beam Radiotherapy for Men with Low-risk Prostate Cancer and May Be a Marker for Occult, High-grade Cancer. International Journal of Radiation Oncology, Biology, Physics, 58, 19-24.
356. Albert, M., Tempany, C.M., Schultz, D., Chen, M.-H., Cormack, R.A., Kumar, S., Hurwitz, M.D., Beard, C., Tuncali, K., O'Leary, M., Topulos, G.P., Valentine, K., Lopes, L., Kanan, A., Kacher, D., Rosato, J., Kooy, H., Jolesz, F., Carr-Locke, D.L., Richie, J.P., and D'Amico, A.V. (2003). Late Genitourinary and Gastrointestinal Toxicity After Magnetic Resonance Image-guided Prostate Brachytherapy with or without Neoadjuvant External Beam Radiation Therapy. Cancer, 98, 949-954.
357. Sinha, D., Ibrahim, J.G., and Chen, M.-H. (2003). A Bayesian Justification of Cox's Partial Likelihood. Biometrika, 90, 629-641.
358. D'Amico, A.V., Moul, J., Carroll, P., Sun, L., Lubeck, D., Chen, M.-H. (2003). Surrogate End Point For Prostate Cancer-Specific Mortality After Radical Prostatectomy Or Radiation Therapy. Journal of the National Cancer Institute, 95, 1376-1383. pdf file
359. Chen, M.-H., He, X., Shao, Q.-M., and Xu, H. (2003). Monte Carlo Gap Test in Computing HPD Regions. In Development of Modern Statistics and Related Topics, eds. H. Zhang and J. Huang, New Jersey: World Scientific, 38-52. pdf file
360. Chen, M.-H. (2003), Discussion on ``On Inferring Effects of Binary Treatments With Unobserved Confounders" by S. Chib. In Bayesian Statistics 7, eds. J.M. Bernardo, M.J. Bayarri, J.O. Berger, A.P. Dawid, D. Heckerman, A.F.M. Smith, and M. West, Oxford: Oxford University Press, 79-82.
361. Ibrahim, J.G., Chen, M.-H., and Sinha, D. (2003). On Optimality Properties of the Power Prior. Journal of the American Statistical Association, 98, 204-213.
362. Chen, M.-H. and Ibrahim, J.G. (2003). Conjugate Priors for Generalized Linear Models. Statistica Sinica, 13, 461-476.
363. D'Amico, A.V., Moul, J., Carroll, P., Sun, L., Lubeck, D., Chen, M.-H. (2003). Cancer Specific Mortality Following Surgery or Radiation for Patients with Clinically Localized Prostate Cancer Managed During the PSA Era. Journal of Clinical Oncology, 21, 2163-2172.
364. D'Amico, A.V., Cote, K., Loffredo, M., Renshaw, A.A., and Chen, M.-H. (2003). Pretreatment Predictors of Time to Cancer Specific Death Following Prostate Specific Antigen Failure. The Journal of Urology, 169, 1320-1324.
365. Chen, M.-H. and Dey, D.K. (2003). Variable Selection for Multivariate Logistic Regression Models. Journal of Statistical Planning and Inference, 111, 37-55. pdf file
366. Chen, M.-H., Ibrahim, J.G., Shao, Q.-M., and Weiss, R.E. (2003). Prior Elicitation for Model Selection and Estimation in Generalized Linear Mixed Models. Journal of Statistical Planning and Inference, 111, 57-76.
367. Cheng, G.C., Chen, M.-H., Whittington, R., Malkowicz, S.B., Schnall, M.D., Tomaszewski, J.E., and D'Amico, A.V. (2003), Clinical Utility of Endorectal MRI in Determining PSA Outcome for Patients with Biopsy Gleason Score 7, PSA < 10, and Clinically Localized Prostate Cancer. Int. J. Radiation Oncology Biology and Physics, 55, 64-70.
368. D'Amico, A.V., Cote, K., Loffredo, M., Renshaw, A.A., and Chen, M.-H. (2003). Advanced Age at Diagnosis is an Independent Predictor of Time to Death from Prostate Carcinoma for Patients Undergoing External Beam Radiation Therapy for Clinically Localized Prostate Carcinoma. Cancer, 97, 56-62.
369. Ghosh, M. and Chen, M.-H. (2002). Bayesian Inference for Matched Case-Control Studies. Sankhya, Series B, Pt. 2, 64, 107-127.
370. Ibrahim, J.G., Chen, M.-H., Lipsitz, S.R. (2002). Bayesian Methods for Generalized Linear Models With Missing Covariates. The Canadian Journal of Statistics, 30, 55-78.
371. Chen, M.-H., Dey, D.K., and Wu, Y. (2002). On Robustness of Choice of Links In Binomial Regression. Calcutta Statistical Association Bulletin, 53, 145-164.
372. Wu, Y., Chen, M.-H., and Dey, D.K. (2002). On the Relationship Between Links for Binary Response Data. Journal of Statistical Studies, Special Volume in Honour of Professor Mir Masoom Ali's 65th Birthday, 159-172.
373. Sinha, D., Ibrahim, J.G., and Chen, M.-H. (2002). Models For Survival Data From Cancer Prevention Studies. Journal of the Royal Statistical Society, Series B, 64, 467-477. postscript file
374. Chen, M.-H., Ibrahim, J.G., and Lipsitz, S.R. (2002). Bayesian Methods for Missing Covariates in Cure Rate Models. Lifetime Data Analysis, 8, 117-146.
375. Chen, M.-H., Harrington, D.P., and Ibrahim, J.G. (2002). Bayesian Cure Rate Models for Malignant Melanoma: A Case Study of ECOG Trial E1690. Applied Statistics, 51, 135-150.
376. Ibrahim, J.G., Chen, M.-H., and Gray, R.J. (2002). Bayesian Models for Gene Expression with DNA Microchip Data. Journal of the American Statistical Association, 97, 88-99. postscript file
377. Chen, M.-H., Ibrahim, J.G., and Sinha, D. (2002). Bayesian Inference For Multivariate Survival Data With a Surviving Fraction. Journal of Multivariate Analysis, 80, 101-126.
378. Chen, M.-H., and Shao, Q.-M. (2002). Partition-Weighted Monte Carlo Estimation. Annals of the Institute of Statistical Mathematics, 54, 338-354. postscript file
379. Chen, M.-H., Shao, Q.-M., and Xu, D. (2002). Sufficient and Necessary Conditions on the Propriety of Posterior Distributions for Generalized Linear Mixed Models. Sankhya, Series A., 64, 57-85.
380. Linson, P., Lee, A., Doytchinova, T., Chen, M.-H., Weinstein, M.H., Richie, J.P., and D'Amico, A.V. (2002). Percentage of Core Lengths Involved with Prostate Cancer: Does It Add to the Percentage of Positive Prostate Biopsies in Predicting Postoperative Prostate-Specific Antigen Outcome for Men with Intermediate-Risk Prostate Cancer? Urology, 59, 704-708
381. Ung, J.O., Richie, J.P., Chen, M.-H., Renshaw, A.A., and D'Amico, A.V. (2002). Evolution of the Presentation, Pathological and Biomehemical Outcomes Following Radical Prostatectomy for Patients with Clinically Localized Prostate Cancer Diagnosed During the PSA Era. Urology, 60, 458-463.
382. Yoon, J.H., Chen, M.-H., Renshaw, A.A., Richie, J.P., and D'Amico, A.V. (2002). Predictive Factor Analysis as the Basis for the Clinical Utility of the Percent Positive Prostate Biopsies in Patients with Intermediate Risk Prostate Cancer. Urology, 60, 454-457.
383. D'Amico, A.V., Whittington, R., Malkowicz, S.B., Cote, K., Loffredo, M., Schultz, D., Chen, M.-H., Tomaszewski, J.E., Renshaw, A.A., Wein, A., and Richie, J.P. (2002). Biochemical Outcome Following Radical Prostatectomy Or External Beam Radiation Therapy For Clinically Localized Prostate Cancer In The PSA Era. Cancer, 95, 281-286.
384. D'Amico, A.V., Saegaert, T., Chen, M.-H., Renshaw, A., George, D., Oh, W., and Kantoff, P.K. (2002). Initial Decline in Hemoglobin during Neoadjuvant Hormonal Therapy Predicts for Early PSA Failure Following Radiation and Hormonal Therapy for Patients with Intermediate and High-Risk Prostate Cancer. Cancer, 95, 275-280.
385. Das, P., Chen, M.-H., Valentine, K., Lopes, L., Cormack, R.A., Renshaw, A.A., Tempany, C.M., Kumar, S., D'Amico, A.V. (2002). Utilizing the Magnitude of PSA Bounce following Magnetic Resonance Image Guided Prostate Brachytherapy to Distinguish Recurrence, Benign Precipitating Factors and Idiopathic Bounce. Int J Radiat Oncol, Biol, Phys., 54, 698-703.
386. D'Amico, A.V., Chen, M.-H., Malkowicz, S.B., Whittington, R., Renshaw A.A., Tomaszewski, J.E., Samofalov, Y., Wein, A., Richiew, J.P. (2002). Lower Prostate Specific Antigen Outcome than Expected following radical prostatectomy for Patients with High-Grade Prostate Cancer and a PSA level of 4 ng/ml or less. The Journal of Urology, 167, 2025-2031.
387. Chen, M.-H. and Ibrahim, J.G. (2001). Maximum Likelihood Methods for Cure Rate Models with Missing Covariates. Biometrics, 57, 43-52.
388. Ibrahim, J.G., Chen, M.-H., and Lipsitz, S.R. (2001). Missing Responses in Generalized Linear Mixed Models When The Missing Data Mechanism is Nonignorable. Biometrika, 88, 551-564.
389. Chen, M.-H. and Shao, Q.-M. (2001). Propriety of Posterior Distribution for Dichotomous Quantal Response Models With General Link Functions. Proceedings of the American Mathematical Society, 129, 293-302. postscript file
390. Ibrahim, J.G., Chen, M.-H., and Sinha, D. (2001). Bayesian Semi-parametric Models for Survival Data with a Cure Fraction. Biometrics, 57, 383-388.
391. Chen, M.-H., Dey, D.K., and Shao, Q.-M. (2001). Bayesian Analysis of Binary Data Using Skewed Logit Models. Calcutta Statistical Association Bulletin, 51, 11-30.
392. Ibrahim, J.G., Chen, M.-H., and Sinha, D. (2001). Criterion Based Methods for Bayesian Model Assessment. Statistica Sinica, 11, 419-443.
393. Chen, M.-H. and Ibrahim, J.G. (2001). Bayesian model comparisons for survival data with a cure fraction. In Bayesian Methods with Applications to Science, Policy and Official Statistics, Luxembourg: Office for Official Publications of the European Communities, 81-90.
394. D'Amico, A.V., Wu, Y., Chen, M.-H., Nash, M., Renshaw, A.A., and Richie, J.P. (2000). Perineural Invasion as a Predictor of Biochemical Outcome Following Radical Prostatectomy for Select Men with Clinically Localized Prostate Cancer. The Journal of Urology, 165, 126-130.
395. Chen, M.-H. and Ibrahim, J.G. (2000). Bayesian Prediction Inference for Time Series Count Data. Biometrics, 56, 678-685.
396. Chen, M.-H., Dey, D.K., and Sinha, D. (2000). Bayesian Analysis of Multivariate Mortality Data With Large Families. Applied Statistics, 49, 129-144.
397. Ibrahim, J.G. and Chen, M.-H. (2000). Power Prior Distributions for Regression Models. Statistical Sciences, 15, 46-60.
398. Chen, M.-H., Ibrahim, J.G., and Shao, Q.-M. (2000). Power Prior Distributions for Generalized Linear Models. Journal of Statistical Planning and Inference, 84, 121-137.
399. Rashid, M.M., Chen, M.-H., and Ganter, S.L. (2000). A Nonparametric Analysis of a Multi-Group Incompletely Ranked Item Response Data. Journal of Nonparametric Statistics, 12, 245-264.
400. D'Amico, A.V., Wu, Y., Chen, M.-H., Nash, M., Renshaw, A.A., and Richie, J.P. (2000). Pathologic Findings and Prostate-Specific Antigen Outcome Following Radical Prostatectomy for Patients Diagnosed on the Basis of a Single Microscopic Focus of Gleason Score 7 or Less Prostate Cancer. Cancer, 89, 1810-1817.
401. D'Amico, A.V., Whittington, R., Malkowicz, S.B., Wu, Y.H., Chen, M.-H., Hurwitz, M., Kantoff, P., Tomaszewski, J.E., Renshaew, A.A., Wein, A., and Richie, J.P. (2000). Utilizing Predictions of Early Prostate-Specific Antigen Failure to Optimize Patient Selection for Adjuvant Therapy Trials. Journal of Clinical Oncology, 18, 3240-3246.
402. Chen, M.-H. and Dey, D.K. (2000). A Unified Bayesian Analysis for Correlated Ordinal Data Models. Brazilian Journal of Probability and Statistics, 14, 87-111.
403. Ghosh, M., Chen, M.-H., Ghosh, A. and Agresti, A. (2000). Hierarchical Bayesian Analysis of Binary Matched Pairs Data. Statistica Sinica, 10, 647-657. pdf file
404. Ghosh, M., Ghosh, A., Chen, M.-H. and Agresti, A. (2000). Bayesian Estimation for Item Response Models. Journal of Statistical Planning and Inference, 88, 99-115. pdf file
405. Ibrahim, J.G., Chen, M.-H., and Ryan, L.-M. (2000). Bayesian Variable Selection for Time Series Count Data. Statistica Sinica, 10, 971-987. pdf file
406. Chen, M.-H., Dey, D.K., and Shao, Q.-M. (1999). A New Skewed Link Model for Dichotomous Quantal Response Data. Journal of the American Statistical Association, 94, 1172-1186.
407. Chen, M.-H., Ibrahim, J.G., and Yiannoutsos, C. (1999). Prior Elicitation, Variable Selection, and Bayesian Computation for Logistic Regression Models. Journal of the Royal Statistical Society, Series B, 61, 223-242.
408. Chen, M.-H. and Shao, Q.-M. (1999). Monte Carlo Estimation of Bayesian Credible and HPD Intervals. Journal of Computational and Graphical Statistics, 8, 69-92.
409. Chen, M.-H., Ibrahim, J.G., and Sinha, D. (1999). A New Bayesian Model For Survival Data With a Surviving Fraction. Journal of the American Statistical Association, 94, 909-919.
410. Chen, M.-H. and Shao, Q.-M. (1999). Properties of Prior and Posterior Distributions for Multivariate Categorical Response Data Models. Journal of Multivariate Analysis, 71, 277-296.
411. D'Amico, A.V., Whittington, R., Malkowicz, S.B., Fondurulia, J., Chen, M.-H., Kaplan, I., Beard, C.J., Tomaszewski, J.E., Renshaw, A., Wein, A., and Coleman, C.N. (1999). A Pre-treatment Nomogram for Prostate Specific Antigen Following Radical Prostatectomy or External Bean Radiation Therapy for Clinically Localized Prostate Cancer. Journal of Clinical Oncology, 17, 168-172.
412. Ibrahim, J.G., Chen, M.-H., and Lipsitz, S.R. (1999). Monte Carlo EM for Missing Covariates in Parametric Regression Models. Biometrics, 55, 591-596.
413. Chen, M.-H. and Shao, Q.-M. (1999). Existence of Bayes Estimators for the Polychotomous Quantal Response Models. Annals of the Institute of Statistical Mathematics, 51, 637-656.
414. Ibrahim, J.G., Lipsitz, S.R., and Chen, M.-H. (1999). Missing Covariates in Generalized Linear Models When The Missing Data Mechanism is Nonignorable. Journal of the Royal Statistical Society, Series B, 61, 173-190.
415. Ibrahim, J.G., Chen, M.-H., and MacEachern, S.N. (1999). Bayesian Variable Selection for Proportional Hazards Models. The Canadian Journal of Statistics, 27, 701-717.
416. Sinha, D., Chen, M.-H., and Ghosh, S.K. (1999). Bayesian Analysis and Model Selection for Interval-censored Survival Data. Biometrics, 55, 585-590.
417. D'Amico, A.V., Whittington, R., Malkowicz, S.B., Fondurulia, J., Chen, M.-H., Tomaszewski, J.E., Wein, A. (1998). The Combination of the Preoperative Prostate Specific Antigen and Postoperative Pathologic Findings to Predict Prostate Specific Antigen Outcome in Clinically Localized Prostate Cancer. The Journal of Urology, 160, 2096-2101.
418. Chen, M.-H. and Dey, D.K. (1998). Bayesian Modeling of Correlated Binary Responses via Scale Mixture of Multivariate Normal Link Functions. Sankhya, Series A, 60, 322-343.
419. Ibrahim, J.G. and Chen, M.-H. (1998). Prior Distributions and Bayesian Computation For Proportional Hazards Models. Sankhya, Series B, 60, 48-64.
420. Chen, M.-H., Manatunga, A.K., and Williams, C.J. (1998). Heritability Estimates From Human Twin Data by Incorporating Historical Prior Information. Biometrics, 54, 1348-1362.
421. Chen, M.-H. and Schmeiser, B.W. (1998). Towards Black-Box Sampling: A Random-Direction Interior-Point Markov Chain Approach. Journal of Computational and Graphical Statistics, 7, 1-22.
422. Chen, M.-H. and Shao, Q.-M. (1998). Monte Carlo Methods on Bayesian Analysis of Constrained Parameter Problems. Biometrika, 85, 73-87.
423. D'Amico, A.V., Desjardin, A.M., Chen, M.-H., Paik, S., Schultz, D., Renshaw, A., Loughlin, K., and Richie, J.P. (1998). Analyzing Outcome-Based Staging for Clinically Localized Adenocarcinoma of the Prostate. Cancer, 83, 2172-2180.
424. Jiroutek, M.R., Chen, M.-H., Johnston, C.C., and Longcope, C. (1998). Changes in Reproductive Hormones and SHBG in a Group of Postmenopausal Women Measured Over 10 Years. Menopause: The Journal of the North American Menopause Society, 5, 90-94.
425. Ibrahim, J.G., Ryan, L.-M., and Chen, M.-H. (1998). Use of Historical Controls to Adjust for Covariates in Trend Tests for Binary Data. Journal of the American Statistical Association, 93, 1282-1293.
426. Chen, M.-H. and Shao, Q.-M. (1997). On Monte Carlo Methods for Estimating Ratios of Normalizing Constants. Annals of Statistics, 25, 4, 1563-1594.
427. Chen, M.-H. and Shao, Q.-M. (1997). Estimating Ratios of Normalizing Constants for Densities with Different Dimensions. Statistica Sinica, 7, 607-630.
428. Dey, D.K., Chen, M.-H., and Chang, H. (1997). Bayesian Approach for the Nonlinear Random Effects Models. Biometrics, 53, 1239-1252.
429. Ibrahim, J.G. and Chen, M.-H. (1997). Predictive Variable Selection For the Multivariate Linear Model. Biometrics, 53, 465-478.
430. Chen, M.-H. and Shao, Q.-M. (1997). Performance Study of Marginal Posterior Density Estimation via Kullback-Leibler Divergence. Test, 6, 321-350.
431. D'Amico, A.V., Chang, H., Holupka, E., Renshaw, A., Desjardin, A., Chen, M.-H., Loughlin, K.R., and Richie, J.P. (1997), Calculated Prostate Cancer Volume: The Optimal Predictor of Actual Cancer Volume and Pathologic Stage. Urology, 49, 385-391.
432. Chen, M.-H. and Deely, J.J. (1996). Bayesian Analysis for a Constrained Linear Multiple Regression Problem for Predicting the New Crop of Apples. Journal of Agricultural, Biological and Environmental Statistics, 1, 467-489. postscript file
433. Chen, M.-H., Nandram, B. and Ross, E.W. (1996). Bayesian Prediction of the Shelf-Life of a Military Ration with Sensory Data. Journal of Agricultural, Biological and Environmental Statistics, 1, 377-392.
434. Nandram, B. and Chen, M.-H. (1996). Accelerating Gibbs Sampler Convergence in the Generalized Linear Models via a Reparameterization. Journal of Statistical Computation and Simulation, 54, 129-144.
435. Chen, M.-H. and Schmeiser, B.W. (1996). General Hit-and-Run Monte Carlo Sampling for Evaluating Multidimensional Integrals. Operations Research Letters, 19, 161-169.
436. Yang, Y. and Chen, M.-H. (1995). Bayesian Analysis for Random Coefficient Regression Models Using Noninformative Priors. Journal of Multivariate Analysis, 55, 283-311.
437. Chen, M.-H. (1994). Importance Weighted Marginal Bayesian Posterior Density Estimation. Journal of the American Statistical Association, 89, 818-824.
438. Chen, M.-H. and Schmeiser, B.W. (1993). Performance of the Gibbs, Hit-and-Run, and Metropolis Samplers. Journal of Computational and Graphical Statistics, 2, 251-272.
439. Berger, J.O. and Chen, M.-H. (1993). Predicting Retirement Patterns: Prediction for a Multinomial Distribution with Constrained Parameter Space. The Statistician, 42, 427-444.

Last modified: April 8, 2024